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ABSTRACT

WHAT TOXICOLOGISTS AND RISK ASSESSORS THINK ABOUT
HORMESIS: RESULTS OF A KNOWLEDGE AND OPINION SURVEY
FEBRUARY 2010
AMY C. JONES
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Edward J. Calabrese
Hormesis is a nonlinear dose-response characterized by biological responses at
low doses that are opposite to those observed at higher doses. Studies and review articles
on hormesis are being published at an increasing rate by researchers from diverse
disciplines and debate has emerged over the role hormesis in risk assessment. As a
result, a survey was conducted to assess toxicologists and risk assessors knowledge and
attitudes about the hormesis dose response. Study goals were to: 1) ascertain attitudes
towards hormesis and other dose-response models, 2) identify whether acceptance or
rejection of hormesis is based on knowledge of hormesis, predisposing values, or
demographic characteristics, and 3) evaluate potential for response bias. The survey
consisted of 44 questions pre-tested by 25 toxicologists and risk assessors. The survey
was distributed via email to the membership of the Society of Toxicology and the Society
for Risk Analysis, 9,500 potential respondents. The overall response rate was 17% (n=
1,463) with a completion rate over 87%. Major findings were that 50% of respondents
indicated sufficient data exist to support the view hormesis occurs across a wide range of
species and endpoints, 59% indicated evaluating potential benefits due to hormesis
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should be included in risk assessments, and 65% are in favor of modifying hazard
assessment protocols to identify the presence of hormesis. Respondent characteristics
such as: years of experience, society membership, education, residence, employment
(excluding government and pharmaceutical companies), and political, economic or social
views had little influence on opinion. One of the largest positive influences was
experience with hormesis based on actual research; 79% of subjects who reported
observing hormesis commonly in their studies agreed hormesis is broadly generalizable.
The influence of non-response bias was evaluated through several internal and external
measures. Despite a lower than hoped for response rate, but because of robust external
validity measures, it is concluded that respondents’ opinions are likely a reasonable
representation of the societies of which they are members. Because this is a baseline
survey, a follow-up survey is in order. Future survey design should separately evaluate
the science of dose-response from the regulatory approach to risk assessment.
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CHAPTER 1
INTRODUCTION

1.1 Background and Purpose of Study
Hormesis is a nonlinear dose-response phenomenon characterized by biological
responses at low doses that are opposite to those observed at higher doses, leading to
either a J-shaped or inverted U-shaped dose-response curve. Evidence for hormesis has
been published in the scientific literature from the late nineteenth century to the present
(Calabrese and Baldwin, 1999; Henschler, 2006). Quantitative analysis of the hormesis
dose-response curve began in earnest with the work of Calabrese and Baldwin (2001a).
Their dose-response database provided the first analysis of the frequency in which the
hormesis dose-response was reported in the scientific literature. This work was followed
by additional frequency analyses and a description of the quantitative features of the
hormesis dose-response (Calabrese and Baldwin, 2001a,b, 2002a,b; Calabrese and Blain,
2005). Results consistent with a hormesis dose-response were shown to be widely
observed in medicine, molecular biology, pharmacology, nutrition, aging/geriatrics,
agriculture, microbiology, immunology, exercise physiology and toxicology.
The data compiled by Calabrese and colleagues, coupled with numerous papers
published by other researchers, indicate that hormesis is common, and highly
generalizable across biological responses in numerous species, both plant and animal. In
December 2007, when the concept for the present study was first developed, an
examination of the PubMed® database, which indexes over 5,000 journals, listed 398
articles with the keyword hormesis that were published between 2000 through 2007.
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Most articles presented original dose-response research for which the author(s) selected
hormesis as a keyword. A summary of the types and content of a number of articles is
included in the literature review in Chapter 2.
Despite the widespread reporting of hormesis research and the inclusion of the
hormesis dose-response phenomenon into leading toxicological textbooks, hormesis as a
model has not been adopted by regulatory agencies or recommended by science policy
experts for conducting hazard assessments. In fact, the utility of hormesis for evaluating
dose-responses from chemical hazard research has been and remains to this day intensely
debated in the scientific literature of the field (Axelrod et al., 2004; Calabrese, 2005 a,b;
Cook and Calabrese 2006a,b; Davis and Farland, 1998; Elliott, 2008a,b; Hoffmann, 2009;
Holsapple and Wallace, 2008; Renn, 2008; Sandin, 2008; Thayer et al., 2006, 2005;
Zapponi and Marcello, 2006).
Outside of the journal-based debate but weighing-in on the topic is the United
States Environmental Protection Agency (EPA). In 2004, the agency implicitly rejected
the use of the hormesis dose-response for conducting chemical hazard assessments and
risk assessments. In a staff paper evaluating its risk assessment process, EPA stated that
“as the purpose of risk assessment is to identify risk (harm, adverse effect, etc.), effects
that appear to be adaptive, non-adverse, or beneficial may not be mentioned” (EPA,
2004). Furthermore, the EPA Guidelines for Carcinogen Risk Assessment (2005) state
that “nonlinear approaches may only be used when data is sufficient to ascertain the
mode of action and (emphasis added by EPA) the agent does not demonstrate mutagenic
or other activity consistent with linearity at low doses”. The guidelines indicate
researchers must use the threshold model as the default model to derive a reference dose
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(RfD) or reference concentration (RfC) when the dose-response is non-linear, thereby
excluding hormesis altogether.
Because evidence of the hormesis dose-response effect is widely reported but still
a matter of debate in the scientific literature, this study was undertaken and designed
using the best available survey methodology to ascertain the prevailing attitudes,
acceptance and reliance on hormesis as a scientifically valid concept among toxicologists
and risk assessors.

1.2 Study Goals
The goals of this first-ever study of the hormesis dose-response concept among
toxicologists and risk assessment professionals were to: 1) ascertain attitudes towards
hormesis and other dose-response models, 2) identify whether the level of acceptance or
rejection of hormesis is based on knowledge of hormesis, predisposing values, or
demographic characteristics, 3) evaluate potential for response bias, and 4) establish
research priorities for hormesis.
This study was designed to provide data that will aid in determining the status of
hormesis as a dose-response concept accepted among toxicologists and to identify
whether the level of acceptance or rejection of hormesis is knowledge-based or
determined by predisposing values, demographic characteristics, and other factors.
Furthermore, it is hoped that the results will enable researchers and regulators to
better understand the direction of toxicological research, hazard assessment, risk
assessment, public health policy development and risk communication as it is influenced
by views on hormesis and other dose-response models.
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CHAPTER 2
REVIEW OF THE LITERATURE

2.1 Survey Methods
The review of survey methods relies strongly on the works of Tanur (1992) and
Fink (1995). Development of sound surveys entails initially setting research objectives,
followed by designing a research methodology to meet the research objectives, preparing
a reliable and valid data collection instrument, administering the instrument, analyzing
data, and reporting the results. Detailed implementation of the guidance provided by
Tanur and Fink is described in Chapter 3: Study Methods. The following is a short review
of survey principles adopted for this survey research on the hormesis dose-response.

2.1.1 Design
The survey instrument must be designed to maximize the validity and reliability
of the research. The researcher must identify the target audience of the survey and
develop relevant questions that are understandable to the target audience. Therefore, the
researcher must fully understand the issues and the respondents before development of
the questions. All ambiguous terms used in the survey’s questions must be clarified and
clearly defined. The survey researcher must assure to the best extent possible that the
respondents have sufficient knowledge to answer the questions. This is usually done by
pre-testing and pilot testing the instrument (Tanur, 1992).
In order to confirm the questions meet that goal they should be reviewed by
subject matter experts and pre-tested by potential respondents. Ideally, survey questions
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and statements should be short and easily read to minimize time on survey (Fink, 1995).
The wording of the question should be such that it does not include biasing words and
phrases and multiple phrases that relay more than one idea (Tanur, 1992).

2.1.2 Ascertaining Attitudes
Attitude is often used to mean opinion, belief, preference, feeling or value, and as
a result, may be difficult to define and measure using a survey instrument. However
scientific and technical methods are available for producing testing attitude scales that are
valid for scientific survey needs. The ability of the questions to obtain information on
attitudes is evaluated by subject matter experts during the design phase. Selection of
pre-testers and pilot testers representative of the target audience is important. They must
have enough knowledge about the subject to have an opinion about it, identify gaps in
knowledge that warrant education or publicity, and help explain attitudes and behavior
Tanur (1992).

2.1.3 Reliability Issues
A reliable survey instrument is one that is relatively free of both random and
measurement error. Non-sampling error results from an imprecise definition of the target
and study population and errors in survey design and measurement. A second nonsampling problem relates to definitions and inclusion and exclusion criteria. Definitions
of key survey concepts should be based on best available theory and practice; pretests and
pilot tests can help eliminate this problem Fink (1995).
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Reliability is also impacted by response rate. Unsolicited surveys receive the
lowest response rate. A 20 percent rate is not uncommon (Fink, 1995; Hamilton, 2003;
Kaplowitz et al., 2004). Survey methodology must be sufficient to promote responses,
minimize response bias, and reduce survey error. This is done by implementing a robust
quality assurance system that keeps the survey responses confidential and anonymous
and by identifying a sufficiently large number of survey recipients that are actually
interested in or knowledgeable about the topic. Reliability is further improved by
utilizing pretesting and pilot testing of questions during the survey design phase Fink
(1995).

2.1.4 Validity Issues
Validity is the degree to which a survey instrument measures what it is purported
to measure. The researcher must focus on assuring both external and internal validity.
External validity refers to the extent to which the results of the study are generalizable.
Internal validity answers whether the survey measures what it intends to measure and is
tested by evaluating inter-item agreement within the survey (Litwin, 1995).

2.2 Hormesis
2.2.1 Background
One of the most common underpinnings of toxicology “the dose makes the
poison” is attributed to Paracelsus, a 16th Century physician and scientist said to be the
“Father of Toxicology”. The saying demonstrates that throughout history many scientists
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have well understood the complexities of biology that occur at low doses. In the 19th
Century, the complexities of low-dose stimulation were evaluated in a series of
experiments conducted by Rudolph Arndt and Hugo Schultz. They documented the
occurrence of biological stimulation at low doses. Their documentation of the biphasic
dose-response phenomenon is known as the Arndt-Shultz Law. However, their work was
widely overlooked possibly due to its association with the controversial medical practice
of homeopathy (Calabrese and Baldwin, 2000a). By the 1940’s the biphasic dose
response became known as hormesis, a term derived from the Greek word meaning “to
excite” (Calabrese and Baldwin, 2000b). The historic development of the concept of
hormesis and the corresponding belief that low doses of toxins could have stimulatory
effects at low doses was detailed in literature reviews by Calabrese and Baldwin
(2001c,d).
Prior to Calabrese and Baldwin’s work, (Smythe, 1967) provided a compelling
review of adaptive responses in the toxicological literature, but did not adopt the term
hormesis. In his review Smythe points out that industrial hygienists were taught that the
human body responds to acute changes with immediate re-adjustments and to repeated
changes with adaptation. Smythe expressed concern that protective technological
advances were producing a generation of people so protected from environmental
changes that they would be less able to adapt to stress. The Smyth review, covering
literature from 1922 through 1966, provides many examples of adaptive responses,
increased growth, positive reproductive outcomes and increased longevity resulting from
low dose exposures to chemicals and ionizing radiation.
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2.2.2 Dose-Response Models
Evaluating, understanding, and applying concepts related to dose-response is the
foundation of toxicology and is directly related to drug discovery and human health risk
assessment. Two dose-response models, threshold and linear non-threshold (LNT), are
traditionally used by regulatory agencies and other public health policy makers, as default
models to describe the dose-response relationship.
The threshold model is used to assess risk posed by non-carcinogenic chemicals.
It is based on the assumption that a threshold exists below which no adverse effects
occur. Toxicological studies are designed to identify that threshold. The data yields a
Lowest Observed Adverse Effect Level (LOAEL), No Observed Adverse Level
(NOAEL), or Benchmark Dose (BMD) from which a “safe dose” is derived. Threshold
model results are input variables, along with exposure data, for conducting human health
and ecological risk assessments.
Regulatory agencies default to the LNT model to assess chemicals thought to be
carcinogenic. The model assumes that if a large quantity of a chemical will cause cancer,
then even a molecule poses a cancer risk (Calabrese and Baldwin, 2001c,d; Calabrese and
Blain, 2005). The only case for which the LNT is not applied is when the chemical under
study can be proven to have a non-genotoxic mode of action and the exact mode of action
is known. Then the threshold model is applied (USEPA, 2005). The LNT model is
carried out in 3 steps 1) high dose studies are designed and conducted to elicit a
carcinogenic response, 2) data are evaluated to derive a point of departure (POD) near the
low end of the observed range and 3) a curve is extrapolated from the POD to zero to
derive a Cancer Slope Factor or Cancer Potency Factor that can be used to conduct a
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human health risk assessment. The model assumes that biological response is directly
proportional to dose without any threshold and that a negative response is always present
down to the last molecule.
Neither the threshold nor LNT model evaluates data in the low-dose region of the
dose response curve. The models were developed to fill in the data gaps that exist in the
low dose range. These gaps exist because toxicological studies are typically designed
with doses sufficiently high to assure the study produces an adverse effect, if one exists.

2.2.3 Hormesis as the Alternative Model
Traditional assumptions about the shape of the dose response continuum are
challenged by the concept of hormesis. The hormetic dose response is a specific type of
non-monotonic dose response characterized by low-dose stimulation and high dose
inhibition. The curve is usually described as either J (U) -shaped or inverted J (U) –
shaped where at low doses the response is opposite to that of high doses (Calabrese and
Baldwin, 2001c,b; Calabrese and Blain, 2005). Calabrese and colleagues have developed
two databases containing thousands of examples of hormesis. Collectively, the data
demonstrate the hormetic dose response is more common than the threshold and LNT
models in head-to-head comparisons and is generalizable across a broad range of toxic
agents, organisms and health endpoints.
The first database contains almost 6,000 dose responses drawn from peer
reviewed literature. In order to be included in the database, the study had to meet the
following a priori entry criteria: 1) strength of study design including ≥6 doses with at
least 3 below the NOAEL, 2) magnitude of stimulation, 3) statistical significance, and 4)
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reproducibility of findings (Calabrese and Baldwin, 1997). Quantitative features of the
dose responses in this database indicate hormetic stimulation (amplitude) is generally
modest with approximately 80% of the responses showing a maximum stimulation
approximately 30-60% greater than the control. The stimulatory range is much more
variable than amplitude, and extends over a dose range of 20-fold or less (Calabrese,
2004a).
The second database was created to address frequency of hormesis in the
toxicological literature. It included a priori entry criteria as well as a priori evaluative
criteria (i.e. a well-defined NOAEL, ≥ 2 doses below the NOAEL, and the endpoint
measured has the capacity to display either stimulatory or inhibitory responses). From
this database, the frequency of hormesis reported in the literature was estimated to be
approximately 40% (Calabrese and Baldwin, 2001c). This database was also used to
assess which dose-response model, hormesis or threshold, occurred more often in the
literature. The majority of dose-responses displayed values greater than the controls.
The hormetic model was more common than the threshold model, suggesting that the
hormetic model may occur 2.5 times more frequently than the threshold model
(Calabrese, 2004b; Calabrese and Baldwin, 2003a; Calabrese and Blain, 2005).
In a comprehensive review of tumor cell literature, Calabrese found that hormesis
occurred in over 130 tumor cell lines. The responses were produced by a wide range of
agents including anti-neoplastics, non-neoplastic drugs, endogenous agonists, and phyto
compounds (Calabrese, 2005b). Hormetic models in yeast data were observed 4 times
more often than would be expected by chance alone (Calabrese et al., 2006).
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Hormetic dose response relationships have been reported by other researchers
specializing in immunology, pharmacology and dietary restriction. Dietary restriction is
reported by Hayes (2006) as the most effective and reproducible laboratory intervention
for extending lifetime survival in diverse organisms. Genome transcription analyses show
the multiple effects antibiotics have on cells at low doses. All antibiotics, regardless of
receptors and mode of action, exhibit the phenomenon of hormesis and provoke
considerable transcription activation at low concentrations (Davies et al. 2006).

It was

proposed that many hormones and other biologicals have reverse effects in biologic
systems depending on their dosage or concentrations and that characteristic may be useful
for developing treatments for malignant tumors (Prehn and Berd, 2006).
The hormesis data are so convincing that this model was recently added to a
leading toxicological text book, Casarett and Doull’s Essentials of Toxicology (Klaassen
and Watkins, 2003). The hormetic effects are hypothesized to occur when relatively low
doses result in the stimulation of a beneficial or protective (adaptive) response, such as,
receptor activity, modulation of DNA repair, the induction of detoxification enzymes,
and/or the induction of cellular antioxidant defense systems (Calabrese, 2005c).
Evidence of hormesis is also reported in the epidemiological literature. Hormeticlike dose response relationships have been observed in the epidemiology literature
(Mundt and May, 2001). However, Mundt and May concluded it was not possible to
discern whether the observation was hormesis or rather the combined effect of several
different biological or disease processes. They provide an example of the dose-response
relationship between alcohol and all-cause mortality. Applying hormesis to this example
however forces the definition to include dose response relationships that incorporate
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diverse causes of mortality and disease mechanisms. Literature reviews support the
hypothesis that hormesis is caused by diverse adaptive response mechanisms (Cook and
Calabrese, 2006a).
The evidence for the hormesis dose-response model and the argument the doseresponse is caused by diverse adaptive biological responses, is strengthening due to
ongoing mechanistic research performed for drug development. A single mechanism for
hormesis has not been identified; however, it appears to operate within a mechanistic
framework that is designed to conserve resources. It may prove to be a modest
overcompensation to a slight disruption in homeostasis (Calabrese, 2004b). Research
studies in biological systems have identified dozens of receptor systems that reliably
demonstrate the hormesis dose response (Calabrese and Baldwin, 2003b; Hadley, 2003).
The significant experimental evidence compiled by Calabrese and others, supports
the conclusion that the hormetic dose responses are broadly generalizable, and are
independent of biological model, endpoint measured, and stressor agent.
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CHAPTER 3
STUDY METHODS

3.1 Introduction
This chapter presents a description of all study procedures and methods, including
selection of the survey target population, development of the survey instrument, survey
administration, and data analysis.

3.2 Identification and Selection of Survey Target Population
The goal of the study is to ascertain expert opinion and attitudes about various
dose-response models, particularly hormesis, and to determine the characteristics of those
who would, if permitted by the regulatory framework, take the hormesis dose-response
into account when designing or interpreting risk assessments. Therefore, professional
societies whose members are known to specialize in toxicology and risk assessment were
chosen for the study. The target societies were the Society of Toxicology (SOT)
(n=approximately 5,800) and the Society for Risk Analysis (SRA) (n=approximately
3,500).
Solicitation of participation from each society and access to the membership lists
are described below. A discussion of the impact of participation, or lack thereof, by the
membership of the societies on the overall study results is provided in Chapter 5:
Discussion of Study Results.
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3.2.1 Society of Toxicology
3.2.1.1 General Description
The Society of Toxicology provides the following description on the public
access portion of its website www.toxicology.org . “The Society of Toxicology (SOT) is
a professional and scholarly organization of scientists from academic institutions,
government, and industry representing the great variety of scientists who practice
toxicology in the U.S. and abroad. SOT is committed to creating a safer and healthier
world by advancing the science of toxicology. The Society promotes the acquisition and
utilization of knowledge in toxicology, aids in the protection of public health, and
facilitates disciplines. The Society has a strong commitment to education in toxicology
and to the recruitment of students and new members into the profession”.
The Society of Toxicology offers several types of membership: Full, Associate,
Postdoctoral, Graduate Student, and Honorary. In order to become a full member, a
toxicologist must have a defined number of years of relevant toxicology experience
depending on highest degree obtained and sponsorship including letters of endorsement
by three full members. The application is then voted on by members of the SOT council
and Membership Committee. The requirements are less stringent for Associate,
Postdoctoral, and Student memberships, but all must demonstrate professional scientific
activities in toxicology or be enrolled in a graduate degree program and be accepted by
the membership committee. The Society consists of approximately 5,800 members
overall who have a broad range of toxicological interests including, but not limited to, the
areas of specialization selected for the demographics portion of this study’s
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questionnaire. This information on SOT member qualifications is important to
understand for analysis of SOT responses.

3.2.1.2 Obtaining the Membership List
The Society was requested to endorse the study in a letter dated June 20, 2008.
Society administrative staff indicated that the request would take several months to
process because it would have to be approved by a newly formed Research/Meeting
Sponsorship Committee. The committee was not scheduled to meet until September
2008. SOT administrative staff indicated that because this researcher is a full member of
the society it would be more expeditious to obtain the needed email addresses from the
membership directory. Therefore, the email addresses were obtained by downloading the
membership directory from the SOT website. The directory is only available to members
using a society provided password. The email distribution list that was downloaded onto
the University list-serve consisted of 5,833 distinct email addresses. This list includes all
members according to SOT administrative staff.

3.2.1.3 Obtaining Society Demographics for Comparing Study Respondents to
Society Membership
The representativeness of the survey research study population can be indirectly
evaluated by comparing survey respondents’ demographic characteristics to the overall
demographic characteristics of the complete population list of the Society. After several
discussions with Society administrative staff followed by a formal request letter, the
Society provided summary statistics on the membership demographics. A copy of the
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request letter is provided in Appendix A. The data provided by SOT included the
following information about members: gender, education, years of experience, and
primary specialty. The Society obtained the membership data from their annual online
membership renewal forms. The society does not mandate that members provide
demographic information; it is voluntary.

3.2.2 Society for Risk Analysis
3.2.2.1 General Description
The Society for Risk Analysis (SRA) provides the following self description on
the public access portion of its website www.sra.org . “The Society for Risk Analysis is
an international interdisciplinary professional society devoted to risk analysis. Members
have interests in risk analysis, risk perception assessment, risk management and risk
communication. The interdisciplinary make-up of the society is aimed at addressing, in
an integrative way, emerging issues in risk analysis. SRA consists of members who
specialize in assessing health, ecological and engineering risks and natural hazards. The
society also explores policy, social and economic implications of risk issues. SRA
membership recruitment is targeted at a wide range of institutions including federal, state
and local governments, industry, academic institutions, not-for-profit organizations, law
firms and consulting groups. SRA members include Risk Analysts, Ecological and
Environmental Scientists, Emergency Preparedness and Response Planners, Engineers,
Health Scientists, Government and Regulatory Officials, Journalists, Lawyers, Natural
and Physical scientists, Policy Analysts, Public Administrators, Safety officers, Social
and Behavioral Scientists, Toxicologists, and Transportation and Infrastructure scientists.
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The Society offers its approximately 3,500 members an opportunity to join any of the
following specialty groups: 1) Biological Stressors, 2) Decision Analysis and Risk, 3)
Dose Response, 4) Ecological Risk Assessment, 5) Economics and Benefits Analysis, 6)
Engineering and Infrastructure, 7) Exposure Assessment, 8) Risk Communication and 9)
Risk Science and Law.”

3.2.2.2 Obtaining the Membership List
The Executive Director of SRA did not respond to written requests, emails, or
phone calls. The email list was therefore, obtained from the online membership directory
available to members using a Society provided username and password. The email
distribution list that was downloaded onto the University list-serve consisted of 3,542
distinct email addresses.

3.2.2.3 Obtaining Society Demographics for Validity Analysis
The SRA did not respond to repeated requests for comparative demographic
information. The impact of the lack of comparative data is discussed in Chapter 5:
Discussion of Results.

3.3 Selection of a Census Survey
A complete census survey, in which the entire population is provided an
opportunity to participate, was selected as the design for this study. Use of a census
survey eliminates concerns about potential sampling bias associated with non-probability
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sampling methods. The concern with a census survey is the potential for non-response
bias.

3.4 Development of the Study Survey Instrument
3.4.1 Choice of Response Category (Dichotomous vs. Likert scale)
The initial drafts of the survey instrument were developed using 5 point Likert
Scale response categories following the convention of placing the negative end of the
scale first. Numbers were assigned to the ordinal data ranked lowest to highest. However,
it could not be determined based on the Likert Scale how participants with a negative
(low) opinion of hormesis quantitatively compared to people with slightly negative, a
neutral, positive (high), or highly positive opinion of hormesis. The assumption that
Likert scales could be treated as ordinal categories did not prove correct for this study.
Subjective hence arbitrary decisions would have had to be made about how to re-code the
data for logistic regression analysis. Thus, the survey was re-written to accommodate
dichotomous responses that would not require re-coding.
During the pre-testing and pilot testing of the questionnaire, some reviewers
suggested use of a Likert Scale because they felt dichotomous responses did not give
respondents with neutral opinions a response option. This suggestion was not adopted
due to concerns about subjective and arbitrary re-coding of the responses.
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3.4.2 Questionnaire Development
The process for revising and creating a valid and reliable survey instrument
includes 1) initial question development, 2) pre-testing and revision, and 3) pilot testing
and revision (Fink, 1995; Tanur, 1992).
The goals for developing a valid questionnaire for the study were the following:
1) make the questions concrete, precise and unambiguous, 2) assure each question
conveyed one thought, 3) eliminate potential for biasing the respondent, 4) develop a
questionnaire that could be answered in less than 20 minutes to keep attrition low, and 5)
assure validity and reliability of the survey instrument.

3.4.3 Questionnaire Documentation
The survey was pre-tested and pilot tested by 25 toxicologists and risk assessors
representing diverse backgrounds and employment. After committee review and
revision, the survey instrument was Beta tested by an independent third party Professor of
Genetics, Toxicology, and Botany at Holy Cross University. The suggested revisions
were to reduce the number of questions and re-word certain questions to assure clarity of
meaning. The revised questionnaire was submitted to four pre-testers. The four were
selected based on their diverse areas of expertise; specifically, general toxicology,
pharmacology, pharmacokinetics and health physics. Their suggestions for wording
changes were adopted. None of the reviewers made substantive content changes. The
questionnaire was then provided to twenty toxicologists and risk assessors for pilot
testing. This group consisted of professionals with advanced degrees and represented all
professional employment sectors of the target population. The pilot test reviewers were
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asked to validate the assumption that the survey could be completed in the desired
timeframe. They were also requested to recommend questions for inclusion or deletion
and to evaluate questions for meaning. Specifically, they were asked to evaluate whether
the questions and statements were clearly written, easy to understand, appropriate to the
audience and unbiased. They were also asked to provide suggestions for additional
content and improvement of content. Although the pilot study was carried out by 20
reviewers, only 12 provided specific written comment. The comments were focused on
clarifying the meaning of specific questions.

3.4.4 The Final Survey Instrument
The final survey instrument consisted of the following:
•

Section 1: Introduction Cover Letter and Informed Consent

•

Section 2: Demographic Data

•

Section 3: Knowledge and Attitudes about Interpreting Dose-Response
Assessments

•

Section 4: Knowledge and Attitudes about the Hormesis Dose-Response

•

Section 5: Knowledge and Attitudes About Risk Assessment Principles and
Practice

•

Section 6: Conclusion and Request for Feedback

3.4.4.1 Section 1: Introduction and Cover Letter
Enticing respondents to complete the survey is critical to increasing response rate
and therefore improving survey validity. An invitation email accompanied the request to
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participate and survey link (Appendix B). The survey instrument Introduction section
repeated the purpose and goals as well as contained the informed consent notification.
The email subject line was worded so that the potential respondent would understand that
the subject matter was hormesis. The email invitation and Introduction incorporated the
following as recommended by Fink (1995):
•

Explain the purpose of the study

•

Describe who is conducting the study

•

Explain how respondents were chosen

•

Provide a realistic estimate of time to complete the survey

•

Explain how confidentiality will be protected

•

Provide the response deadline

•

Provide instructions for completing the survey

•

Provide researcher contact information

•

Provide examples of how the data will be made available to the respondents

•

Provide the informed consent

3.4.4.2 Section 2: Demographic Data
While the concept for this survey was being developed, it was thought that a
respondent’s knowledge and opinions about risk assessment in general and hormesis in
particular may vary by gender, age, education, experience, type of employment, specialty
and subspecialty, as well as social, economic, and political views, and these variables
were taken into account with the final selection of demographic variables for analysis.
Further, four of the five research goals depend on obtaining and interpreting respondent
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demographic data. Demographic variables were chosen based on the research goals of
identifying characteristics of respondents which may influence attitudes towards
hormesis when interpreting risk assessment results, and in order to be inclusive of a wide
variety of employment areas and specialties in toxicology that could be used in the
analysis.
The survey was designed to keep attrition rates as low as possible by placing the
request for demographic information at the front of the survey (Andrews et al., 2003;
Fink, 1995).

3.4.4.3 Documentation of Final Subject Matter Questions
The knowledge and opinion questions are contained in Sections 3, 4 and 5. In
order to assist the respondent in answering the questions figures depicting the linear nonthreshold, threshold, and J-shaped hormesis dose response curves were inserted at the
beginning of each section. Documentation of each question and the purpose for asking
the question is presented in Appendix C.

3.4.4.4 Final Questionnaire
The final version of the questionnaire contained 46 coded statements, including a
question at the beginning asking the participant if he/she had taken the survey before and
2 open-ended questions at the end of the survey instrument asking the participant for
comments on missed content and survey quality. The first question “If you have taken
this survey before, please skip to the end” was added because respondents could have
been sent two different survey links if they were members of both SOT and SRA. If the
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person answered yes to question 1, they were sent to the end page thanking them for their
participation.

3.5 University of Massachusetts Human Subjects Requirements
This study was carried out in compliance with 45 CFR 46 and guidelines set forth
by The University of Massachusetts Human Research Protection Office (HRPO). The
office assures protection of the rights and welfare of human subjects in accordance with
federal regulations and the campus Federal Wide Assurance issued by the U.S.
Department of Health and Human Services. The study was approved by the Internal
Review Board (IRB) on August 22, 2008. The study qualified for expedited review
within the School of Public Health because it involved no more than minimal risk to
subjects. The review was coordinated by Linda Downs-Bembury and Dr. Richard Van
Emmerik.

3.5.1 IRB Form and Training
The Abstract of Research Plan, Form ADM 441 and Cover Letter submitted to the
IRB are archived in this researcher’s academic record. The required training in
protection of human subjects was completed on October 14, 2007 including the required
training module for “Social and Behavioral Research Investigators and Key Personnel”
and the optional training module for “Internet Research.” The Collaborative Institutional
Training Initiative (CITI) completion certificate is archived in this researcher’s academic
record. The training was invaluable in assuring the questionnaire was designed to
comply with the Belmont Principles of respect for persons, benefice and justice.
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3.5.2 Informed Consent
Federal requirements followed by the University require that investigators
conducting human research obtain the consent of the subject. The purpose of informed
consent is to educate potential respondents about the purpose of the study, research
procedures, and risks and anticipated benefits of participation. The informed consent was
included in the Introduction section of the survey. The purpose, risks and benefits of the
survey were explained. The respondents were assured that their responses would be
confidential and anonymous. They were offered an opportunity to ask questions and
were provided this researcher’s telephone number and email address. Potential
respondents were informed they could withdraw from the survey at any time and could
choose not to answer all questions. Accordingly, the web based survey did not force the
respondent to answer a question before proceeding to the next question.

3.5.3 Privacy and Anonymity
Protecting privacy is paramount when conducting survey research. Web-based
surveys provide researchers more opportunity to inadvertently violate privacy than in
conventional surveys. For example, email pre-notification, the survey itself, and followup could be considered unsolicited “spam”. The goal is to build trust to encourage people
to participate so they do not feel “spammed” or exploited. Therefore, the survey was
delivered through the University list-serve from this researcher’s personal email address.
Because the survey was being sent to a broad range of potential respondents,
including government employees, it was designed for all responses to be anonymous,
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thus eliciting candid answers. All respondents were assigned a survey ID number
through the web-based survey tool. The tool’s database recorded the ID tagged to a
specific email address and the survey was entered by a link embedded in the email. By
separating the survey from the email, privacy issues around email (work monitored email,
multiple users having access to password protected email accounts) were minimized.
The only respondents who could be personally identified are those who contacted
me personally to ask questions or make comments. Even in such a situation, their
responses remained anonymous because they were maintained in the separate third party
database. Protection of privacy is further discussed in the following section, survey
administration.

3.6 Survey Administration
3.6.1 SurveyMonkey®
The SurveyMonkey ® tool was chosen for survey administration because 1) there
is extensively documented research indicating that it protects respondent privacy and
anonymity, and 2) respondents may have familiarity with this tool because it is used
extensively by professional societies to administer opinion surveys and for distributing
ballots for voting on candidates for various society and specialty section elections.
The weblink “collector” provided by SurveyMonkey ® for each distribution list
allowed only one response per unique link and enabled IP address blocking so the survey
could not be sent from the recipient to others who were not members of either SOT or
SRA. SurveyMonkey® has established a strong privacy policy and anti-spamming
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agreement. Therefore, the email and survey link contained an “opt out” remove link field
so that reminders would not be forced upon an unwilling recipient.

3.6.2 Distribution and Reminders
Separate email list-serve distribution lists were established for each of the two
societies. The survey was distributed via email to 9,375 potential respondents, all of
whom were members of either the Society of Toxicology (n=5,833) or the Society for
Risk Analysis (n=3,542). The initial invitation to participate was emailed on August 26,
2008. Reminders were sent on September 9th and September 24th. The survey closed on
October 7, 2008.

3.7 Data Analysis
3.7.1 Introduction
The goal of the data analysis was to identify relationships between variables, to
make comparisons between demographic groups and other logical groupings of variables,
and ultimately to determine how acceptance or rejection of hormesis relates to knowledge
of the subject, predisposing values, or demographic characteristics. The analysis for this
study was carried out in several stages as described below.

3.7.2 Data Management and Variable Codes
Descriptive statistics provided by SurveyMonkey ® were downloaded and are
summarized in tables in Chapter 4. The raw data were downloaded from
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SurveyMonkey® as comma separated value (CSV) ASCII text files. SAS software,
version 9.2 SAS Institute, Inc, Carey, NC was used to convert the CSV files into a single
SAS data set containing all question responses, comments, and metadata, such as survey
start and end times and the unique respondent ID assigned by the SurveyMonkey ® tool.
Data management included the following:
1) Removing invalid responses and duplicate survey returns. SurveyMonkey ®
retains a record of everyone who opened the survey but did not answer any
questions. These subjects were removed from the database prior to any analysis.
Because a respondent could have received the survey from both distribution lists,
as described above, duplicate survey returns were removed by treating returns
with identical gender, state of residence, and date of birth as a duplicates.
2) People who completed the demographic portion of the survey and answered at
least one of the first five questions in Section 3 were categorized as respondents.
3) Logical groupings of demographic characteristics were developed to facilitate
analysis. Examples include, but are not limited to, work experience categories
(based on years of experience), employment type (e.g. industry, academia, and
government), and specialty type (e.g. combining reproductive and developmental
specialties).
4) Additional variables were created for time spent on survey by the study
participant and whether a respondent completed the survey. The survey was
considered complete if the respondent answered any of the last four survey
questions.

27

3.7.3 Descriptive Statistics
Respondent characteristics of all validated data were summarized for all
demographic variables, type of employment and specialty. Overall response rate and
response rate by society membership were calculated. Completion rate was calculated by
the key demographic variables of gender, professional society membership and
education.

3.7.4 Univariate and Joint Analysis
The textbook Biostatistics: A Foundation for Analysis in the Health Sciences
(Daniel, 1995) and the SAS Procedures Guide, Version 6, Third Edition (SAS, 1990)
served as the basic foundation for identifying the appropriate statistical tests to apply to
the data. Odds ratios (OR) with 95% confidence intervals (CI) estimated through logistic
regression analysis were used to identify demographic characteristics of those who
accept/reject hormesis and to identify the characteristics of subjects most likely to use
hormesis for risk assessment.

3.7.4.1 Tests for Association
The chi-square test statistic was used to compare frequencies for categorical
variables (Daniel, 1995, p. 516). The test chi-square test compares observed frequencies
to expected frequencies. Examples of null hypotheses for this study are: no difference
between male and female respondents, no difference between educational categories, and
no difference between various employment categories. The chi-square output was
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scanned to identify significant (p<0.05) heterogeneity in responses among and between
demographic variables.

3.7.4.2 Univariate Analyses of Associations
The variables that were found to be statistically significant across most questions
were further evaluated by calculating odds ratios to examine the odds that a category of
respondents agreed or disagreed with the idea asked by the policy questions described
below. Frequency data were entered into 2x2 tables. Respondents were dichotomized
(e.g. male/female, SOT/SRA, EverEPA/All other employers) with respect to whether
they agreed or disagreed with the question. The OR along with its 95% CI was
calculated using standard methods (Daniel, 1995, p.547).
Evaluation of statistical significance was accomplished by examining the upper
and lower bounds of the 95% CI. If the lower bound of the CI was >1.0 or the upper
bound was <1.0, then the estimated odds ratio was deemed statistically significantly
different from the null odds ratio of 1.0.

3.7.4.3 Multivariate Analyses
The logistic regression model is employed when the dependent variable is
dichotomous. Logistic regression allows one to estimate the ORs for several variables of
interest, permitting the identification of variables that remain significantly associated
with the dependent variable when adjusted for the effects of other candidate covariates.
It is the most widely used statistical model for evaluating several characteristics which
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are independently associated with a particular dichotomous outcome (Daniel, 1995, p.
484).
Logistic regression modeling was carried out only on the questions of interest
described below. For those questions ORs with upper and lower bounds satisfying the
criteria for statistical significance were included in a logistic regression model to
determine the characteristics associated with the “agree” response in a multivariate
analysis. A step-wise model was developed for variables that might be highly correlated
such as the general categorical variable employment at a regulatory agency and specific
categorical variable employment at the USEPA.

3.7.5 Selecting Specific Questions for Univariate and Multivariate Analysis
All questions in the survey instrument are important for gaining an understanding
of respondents overall knowledge and opinions about risk assessment and the hormesis
dose-response. Four questions were singled out for detailed analysis because they
provided answers to the specific research question regarding who would take hormesis
into consideration when designing or interpreting risk assessments. The selection of four
“policy questions” is described below.
The first policy question is number 32. It covers the basic tenants of review
papers and original research published by Calabrese and others that sufficient data exist
to suggest hormesis occurs in a wide range of species and endpoints following low-dose
exposure to a broad range of chemical agents and physical stressors.
The second policy question is number 36. It was designed to evaluate whether
hormesis could be accepted in risk assessment to obtain potential benefit. This question
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is meant to get to the heart of the hormesis debate detailed in Chapter 2: Review of the
Literature. Question 36 was also selected for comment analysis. An a priori concern of
the research committee was that only people with a strong positive or negative opinion
about hormesis would take the time to answer a detailed questionnaire on the topic. This
question was selected for comment analysis because EPA guidance specifically states
benefit cannot be taken into account when determining a safe dose (EPA, 2004) thus, this
question more than the others could have elicited a “passionate” comment.
The third policy question is number 38. Many regulations in place today are
based on the linear non-threshold and threshold dose-response models. Question 38 asks
the respondent to consider a situation in which hormesis is the default model for risk
assessment. The question serves as an important indicator of the impact hormesis could
have on the regulatory framework.
The fourth policy question is number 39. This question asks the participant to
consider the current state of knowledge about hormesis and provide an opinion as to
whether the phenomenon justifies a change in hazard assessment methodology. The
question is an important indicator of the impact hormesis could have on the design of
dose-response experiments.
In addition to the four policy questions, there was also interest in evaluating how
respondents with direct experience in dose-response research and who reported observing
one or more of the various dose-response curves pictured in the questionnaire, viewed
the four policy questions. Therefore the response to question 26 which asks a respondent
to report how commonly he/she has observed hormesis was compared with whether the
respondent agreed to questions 32, 36, 38 and 39.
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3.7.6 Internal Consistency Analysis
Measures of internal consistency answer whether the survey measures what it
intends to measure. It is tested by evaluating inter-item agreement within the survey.
Chronbach’s Coefficient Alpha is a statistical measure of internal reliability commonly
used to assess survey instruments. It is applied to groups of questions designed to
measure different aspects of the same concept. Although single items may be quicker to
administer, the data set is richer and more reliable if several different items are used to
gain information about a particular attitude or opinion (Litwin, 1995). The calculation of
Alpha statistical test to evaluate internal consistency was carried out using standard
equations and procedures (SAS Procedures Guide, 1990).
Two tests for internal consistency were built into the questionnaire. The
following questions were designed to take one or more measures on the subject’s attitude
or knowledge about a particular risk assessment, policy or hormesis topic. The first test
was disagree response to question 15 vs. an agree response to question 19. Both evaluate
the respondent’s opinion on the current dose response default model for cancer risk
assessment. The second test was agree response to question 31 vs. an agree response
question 41. Both indicate whether the respondent shows a consistent understanding of Jshaped dose-response curve depicted in the figures.

3.7.7 Evaluation of Response Bias
In order to address concerns about response bias the characteristics of those who
completed the survey were compared to those who dropped out along the way. Chi-

32

square tests were used to identify statistically significant differences by demographic
variable.
Auxiliary information provided by SOT was used to compare the overall
demographic characteristics of the entire membership of the society to the demographics
of study respondents. This analysis was also used as an indirect assessment of external
validity in assessing whether the survey results may be generalizable to the survey target
population and participating societies.
An independent study provided by researchers conducting a similar survey on the
SOT membership three months after the present survey was also used to evaluate validity
of overall study results.
The research committee suggested coding comments to Questions 36, 45 and 46
as to whether they were negative, neutral, or positive toward hormesis in an effort to
indirectly evaluate response bias. It is acknowledged that this coding is subjective. For
the purposes of this study, if comments were overwhelmingly positive or negative, over
20% in either direction, it was concluded response bias could be present. If however, the
overwhelming majority of comments, 80%, were neutral then it was concluded response
bias may be low.
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CHAPTER 4
RESULTS

4.1 Introduction
This chapter presents the study results. The order of presentation follows the
methods outlined in Chapter 3, beginning with summary of response rate, completion
rate, respondent characteristics, and descriptive statistics for each question. This is
followed by univariate and multivariate logistic regression analysis of the four policy
questions and the dose-response research question, internal consistency analysis and
evaluation of potential response bias. Interpretation and discussion of findings are in
Chapter 5.

4.2 Descriptive Statistics
4.2.1 Response Rate
The internet survey invitation link was sent via email to 5,833 Society of
Toxicology members and 3, 542 Society for Risk Analysis members. SurveyMonkey®
recorded a total of 1,882 potential respondents opening the email link. Of that number,
1,326 opened the SOT survey link providing an overall response rate of 23%; and 556
opened the SRA survey link providing an overall response rate of 16%. All 1,882
responses were downloaded into the SAS database as described in Chapter 3. The
questionnaires with missing data (n=221) and duplicates (n=15) were removed. The low
number of duplicates suggests few respondents attempted to answer the survey more than
once as a result of receiving two invitations, one from each of the two distribution lists.
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The adjusted response rates after missing and duplicates were removed are 20% and 14%,
respectively. A total of 183 subjects completed the demographic portion of the survey,
but did not answer the remaining questions. These 183 subjects tended to be female
(14% were female vs. 8% who were male), belong to the Society for Risk Analysis (14%
were members of SRA vs. 10% who were members of SOT), and have less experience
(16% had 0-9 years of experience vs. 5% who had over 30 years of experience). The
response rate adjusting for people who stopped the survey after the demographics section
was 18% (n=1, 045) for SOT and 12% (n= 418) for SRA. Overall and adjusted response
rates are presented in Figure 4.1. Subjects who completed the demographic questions
and answered at least one of the first four subject matter questions (questions 14 -17)
were classified as respondents. Twenty-three email addresses (6 for SOT and 17 for
SRA) were returned as undeliverable. This was not enough to materially affect the
response rate for either society. The list-serve recorded over 200 bounces, automatic
replies such as out of office indicators. These bounces were not considered undeliverable
in calculating response rate because it is possible that the subject could have eventually
opened the survey link and answered the questionnaire, provided they returned to their
email prior to survey close on October 7, 2008. Because the survey was anonymous, it is
not known whether the bounced email recipients answered the questionnaire.
Most respondents completed the questionnaire on or near the dates of the initial
invitation or on or near the dates of the reminders as shown in Figure 4.2.
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n=1,646

Remove Respondents who answered demographic section only (n=183)

SOT
n = 1,045
Response = 18%

.

SRA
n = 418
Response = 12%

Respondents
n=1,463

.

Figure 4.1: Flow diagram of overall response rate and adjusted response rate

4.2.2 Completion Rate
4.2.2.1 Completion Rate by Question
Completion rate was evaluated by question and by demographic variables of
interest. Completion rate by question was calculated based on the 1,463 respondents who
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Figure 4.2: Frequency diagram of questionnaire responses by date. The spikes
correspond with initial invitation 8/26 and subsequent reminder dates of 9/8 and
9/24
completed the demographic section and continued the survey through question 43.
Completion rate by question, starting with question 14 is presented in Table 4.1.

4.2.2.2 Completion Rate by Demographic Variables of Interest
Completion rate was plotted by years of experience and gender. To be
considered complete, the respondent must have continued the survey through question
42, 43, or 44. Experienced men tended to have a higher completion rate in most
categories of years of experience than women. The only exception was for women with
10-19 years experience (Figure 4.3).
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Table 4.1: Completion rate by question
Question

Responses

14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44

1483
1411
1435
1437
1444
1392
1410
1410
1412
1320
1225
1442
1143
1383
1345
1196
1347
1320
1217
1315
1251
1101
1245
1291
1235
1230
1186
1239
1247
1234
1150
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%
Complete
100
95
96
97
97
94
95
95
95
89
83
97
77
93
91
81
91
89
82
87
84
74
84
87
83
83
80
83
84
83
78

Figure 4.3: Completion rate by years of experience and gender

On average, the SOT and SRA response rates differed by society with the SOT
response rate consistently higher regardless of years of experience. Response rates for
both societies increased with increased years of experience (Figure 4.4).
Completion rates were examined by years of experience and by highest attained
degree (Figure 4.5). The respondents with bachelor and master degrees tended to have
lower completion rates, except among those with the highest years of experience.
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Figure 4.4: Completion rate by years of experience and society membership
Chi-square tests and multivariate regression analysis of the variables of interest
(gender, society membership, highest attained degree, and years of experience) indicate
subjects who completed the survey are not statistically different from those who started
the survey. The only statistically significant variable was 0-9 years experience. The
multivariate logistic regression analysis results are shown in Table 4.2.
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Figure 4.5: Completion rate by experience and highest degree attained

Table 4.2: Multivariate logistic regression analysis results comparing subjects who
completed the survey to those who did not complete
Covariate

Gender
Male
Female
Education
PhD
BS, MS, JD, MD,
DVM
Society
SOT
SRA
Experience
30 or more Years
0-9 Years
10-19 Years
20-29 Years

Completed
Survey
No.
%

Did not
Complete
No.
%

Adjusted
Odds Ratio

95% CI
Adjusted OR

863
385

88
86

120
62

12
14

1.00
0.99

Reference
0.70, 1.40

1004
264

88
85

142
46

12
15

1.00
1.11

Reference
0.76, 1.64

921
352

88
84

124
66

12
16

1.00
0.78

Reference
0.55, 1.11

299
351
274
344

90
85
87
87

32
63
41
53

10
15
13
13

1.00
0.58
0.80
0.76

Reference
0.36, 0.94
0.48, 1.35
0.47, 1.24
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4.2.3 Respondent Characteristics
Examination of demographic variables allows for characterization of respondents.
Respondent characteristics are summarized for all demographic variables, type of
employment and specialty for the 1,463 people who answered the subject matter content
questions of the questionnaire. Table 4.3 (top panel) provides a summary of the
demographic variables by society. The table shows that among respondents gender
distribution is identical between societies. The SRA respondent group had fewer PhD’s
but more master’s degrees for highest attained degree. The frequency distributions by
society for political, economic, and social views (Table 4.3 bottom panel) were for the
most part remarkably similar among respondents from the different groups.
Examination by type of employment and society membership shows considerable
similarity. The largest differences are seen between society members ever employed by
the pharmaceutical industry and members ever employed in environmental consulting
(Table 4.4).
Comparison of specialties by society shows the fundamental differences in society
membership as described in Chapter 3 (Table 4.5). The SOT respondent group consists
of subjects who specialize in general toxicology with a variety of toxicological subspecialties. The SRA respondent group consists mainly of subjects with specialties in
risk assessment, policy, and public health.
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Table 4.3: Summary of demographic and political, economic, and social views by
society
Characteristic
Gender
Male
Female
Education
Bachelor’s
Master’s
PhD
MD/JD/DVM
Experience in Years
0-9
10-19
20-29
≥ 30
Political Issues
Conservative
Middle of the Road
Liberal
Choose not to Respond
Economic Issues
Conservative
Middle of the Road
Liberal
Choose not to Respond
Social Issues
Conservative
Middle of the Road
Liberal
Choose not to Respond

Society of Toxicology
No.
%

Society for Risk Analysis
No.
%

739
338

68.6
31.4

281
130

68.4
31.6

52
93
924
31

4.7
8.4
83.8
2.8

17
96
288
15

4.0
22.9
68.6
3.6

331
220
279
269

30.1
20.0
25.4
24.5

85
98
142
92

20.4
23.5
34.1
22.1

150
466
397
82

13.7
42.6
36.3
7.5

52
157
176
33

12.4
37.6
42.1
7.9

278
558
190
67

25.4
51.1
17.4
6.1

105
192
92
27

25.2
46.2
22.1
6.5

141
445
431
75

12.9
40.8
39.5
6.9

47
120
223
27

11.3
28.8
53.5
6.5

43

Table 4.4: Summary of responses for employment area by society
Characteristic

1

Government
NASA
EPA
OSHA
CDC
DOE
FDA
State
International
Other
Industry
Pharmaceutical
General Manufacturing
Defense
Petrochemical
Chemical
Environmental Consulting
Toxicological Consult/Res.
Academic
Administrative
Faculty
Medical Faculty
Post-Doctoral Researcher
Graduate Student
Other
Non-governmental Org
Retired

Society of Toxicology
No.
%1

Society for Risk Analysis
No.
%1

.
95
2
12
11
29
36
13
57

.
8.6
0.2
1.1
1.0
2.6
5.2
1.2
5.2

3
56
2
3
14
13
33
10
30

0.7
13.3
0.5
0.7
3.3
3.1
7.9
2.4
7.1

225
34
5
31
90
58
223

20.4
3.1
0.5
2.8
8.2
5.3
20.2

12
8
11
13
18
98
71

2.9
1.9
2.6
3.1
4.3
23.3
16.9

27
279
36
80
85

2.5
25.3
3.3
7.3
7.7

14
104
7
16
18

3.3
24.8
1.7
3.8
4.3

43
65

3.9
5.9

24
28

5.7
6.7

Frequencies do not add up to 100% because the respondent was able to select all
employment categories that applied to their career experience
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Table 4.5: Summary of responses by field of specialty
Specialty

1

General Toxicology
Risk Assessment
Regulatory Policy
Mechanistic
Carcinogenesis
Pharmacology
Public Health
Molecular
Developmental/Reproductive
Occupational
Inhalation/Respiratory
Neurotoxicology
Immunotoxicology
Biological Modeling
Pathology
Dermal
Veterinary
Ecology
Food Safety

Society of Toxicology
No.
%1
783
71.1
411
37.3
174
15.8
275
25.0
230
20.9
214
19.4
144
13.1
202
18.3
196
17.8
112
10.2
151
13.7
156
14.2
120
10.9
77
7.0
78
7.1
49
4.4
49
4.4
33
3.0
100
9.1

Society for Risk Analysis
No.
%1
159
37.9
361
86.0
151
36.0
36
8.6
62
14.8
16
3.8
144
34.3
20
4.8
23
5.5
65
15.5
45
10.7
22
5.2
9
2.1
55
13.1
9
2.1
13
3.1
8
1.9
40
9.5
47
11.2

Frequencies do not add up to 100% because the respondent was able to select all
employment categories that applied to their career experience.

4.2.4 Summary Statistics by Question
Summary statistics for Section 3: Knowledge and Attitudes about Interpreting
Dose-Response Assessments; Section 4: Knowledge and Attitudes about the Hormesis
Dose-Response; and Section 5: Knowledge and Attitudes about Risk Assessment
Principles and Practice were calculated based on responses from the 1,463 subjects who
continued the questionnaire after completing the demographic section. In all cases the
summary statistics were calculated for responses only and do not include missing values.
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4.2.4.1 Knowledge and Opinions about Interpreting Dose-Response Assessments
Section 3 contained thirteen knowledge and opinion questions meant to ascertain
respondent attitudes about interpreting dose-response assessments. The first of the
thirteen questions was a basic statement that dose-response assessment is the necessary
foundation for risk assessment. The statement was met with virtually unanimous
agreement (98%). The respondents generally disagreed (75%) with the current approach
used by regulatory agencies to assess cancer risks. Respondents were closely split as to
whether exposure to genotoxic carcinogens (57% agree vs. 43% disagree) or ionizing
radiation (52% agree vs. 48% disagree) always leads to increased risk of developing of
cancer regardless of how low the dose. Respondents disagreed for the most part (80%)
that non-genotoxic carcinogens always lead to increased risk of cancer regardless of how
low the dose. The section contained three questions about definitions of the threshold,
linear non-threshold, and hormesis dose-response models. Respondents generally agreed
(> 80%) with each definition provided. Most respondents (69%) think non-carcinogenic
toxicants act in a manner consistent with the threshold dose-response model and over half
(53%) think carcinogenic compounds follow the threshold model. At the end of the
section respondents were asked to report their first-hand experience with various doseresponse models. The threshold dose-response was reported to be observed commonly
and occasionally (n=1019), followed by linear-non-threshold (n=629) then hormesis
(n=555). Many who conduct dose-response research (n=233) commented that most
studies are not designed to detect hormesis. The summary results for this section are
found in Table 4.6.
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Table 4.6: Summary statistics for Section 3 “Knowledge and Attitudes about Interpreting Dose-Response Assessments.”
Question
Q14. Dose-response assessment is a necessary foundation for understanding risk
assessment.

47

Q15. Regulatory upper-bound characterizations used in cancer risk assessments provide
accurate estimates of the probability of developing cancer at low doses.
Q16. Exposure to a genotoxic carcinogen, no matter how small, theoretically results in an
increased cancer risk.
Q17. Exposure to a non-genotoxic carcinogen, no matter how small, theoretically results
in an increased cancer risk.
Q 18. Exposure to ionizing radiation (e.g. x-rays), no matter how small, theoretically
results in increased cancer risk.
Q19. The linear model employed in cancer risk assessment overstates risk in the low dose
zone.
Q20. The threshold dose-response assumes no treatment related responses occur below the
estimated threshold.
Q21. The linear non-threshold (LNT) dose-response assumes a biological response is
directly proportional to dose in the low dose zone.
Q22. The hormesis dose-response exhibits biological responses at low doses that are
opposite to those observed at higher doses, leading to either a J-shaped or inverted Ushaped dose-response curve.
Q23. For effects other than carcinogenesis, most toxicants act in a manner consistent with
the following model:
Q24. Carcinogens typically act via the following dose-response model:
Q25. Have you ever conducted experimental research in dose-response?
Q26 a. In my research biological responses that best fit the threshold model are observed:
Q26 b. In my research biological responses that best fit the linear non-threshold model are
observed:
Q26 c. In my research biological responses that best fit the hormesis model are observed:

Agree
98% (1457)
Generally Agree
25% (358)
Generally Agree
57% (827)
Generally Agree
20% (285)
Generally Agree
52% (745)
Generally Agree
83% (1157)
Generally Agree
80% (1122)
Generally Agree
88% (1247)
Generally Agree
93% (1318)

Responses
Disagree
2% (26)
Generally Disagree
75% (1053)
Generally Disagree
43% (608)
Generally Disagree
80% (1152)
Generally Disagree
48% (699)
Generally Disagree
17% (285)
Generally Disagree
20% (288)
Generally Disagree
12% (163)
Generally Disagree
7% (94)

Threshold
LNT
Hormetic
69% (907)
14% (188)
17% (225)
Threshold
LNT
Hormetic
53% (649)
34% (414)
13% (162)
Yes 65% (946)
No 35% (496)
Commonly
Occasionally Rarely
Never
68% (759)
23% (260)
6% (63)
3% (39)
Commonly
Occasionally Rarely
Never
22% (237)
36% (392)
28% (309) 14% (153)
Commonly
Occasionally Rarely
Never
12% (127)
39% (428)
33% (366) 16% (171)

4.2.4.2 Knowledge and Opinions about Interpreting the Hormesis Dose-Response
Section 4 contained seven questions about the subject’s knowledge and attitudes
regarding hormesis dose-response. The first question was a query to ascertain how many
respondents learned of hormesis in person by attending a seminar, workshop, conference
or classroom instruction. Most respondents had no experience with any type of personal
instruction on the topic. The second question asked about how commonly the
respondent thought hormesis is reproducibly observed in a variety of study types. Most
respondents either thought hormesis occurred 5-20% of the time (approximately 25% of
respondents) or selected “do not know” (approximately 35% of respondents). Of the
respondents who selected “do not know” 60% thought hormesis had not been adequately
studied. The remaining questions in the section addressed the interpretation of doseresponse models. A large majority (86%) thought biological responses to toxicant and
radiation exposure were not necessarily adverse. A majority (64%) also thought the Jshaped dose response could implicate beneficial effects at low doses. Question 32, the
first of four policy questions made the statement that sufficient data exist to suggest
hormesis occurs in a wide range of species and endpoints following low-dose exposure to
a broad range of chemical agents and physical stressors. Respondents were evenly
divided on the topic. This question is analyzed in detail later in this chapter in the section
on univariate and joint analysis. The last question of the section asked about the
interpretation of the hormesis dose-response. A majority (71%) thought that the
phenomenon of hormesis was either beneficial or harmful, depending on the biological
response. The responses to all questions in this section are summarized in Table 4.7.
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Table 4.7: Summary statistics for Section 4 “Knowledge and Attitudes about the Hormesis Dose-Response”
Question
Q27 a. Have you ever attended a hormesis seminar?
Q27 b. Have you ever attended a hormesis workshop?
Q27 c. Have you ever attended a hormesis conference?
Q27 d. Have you ever attended classroom instruction on hormesis?
Q28 a. How commonly do you think hormesis is reproducible observed
in chemical toxicity studies?
Q28 b. How commonly do you think hormesis is reproducible observed
in chemical carcinogen studies?
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Q28 c. How commonly do you think hormesis is reproducible observed
in ionizing radiation studies?
Q28 d. How commonly do you think hormesis is reproducible observed
in human epidemiology studies?
Q29. If you answered (5-20%),(1-5%), (~0%), or do not know, to the
preceding question is it because you believe hormesis :
Q30. Any reproducible biological response to a toxic chemical or
radiation exposure qualifies as an “adverse effect.”
Q31. If a study reliably shows a J-shaped dose-response curve, it implies
low dose effects could be beneficial.
Q32. Sufficient data exist to suggest hormesis occurs in a wide range of
species and endpoints following low-dose exposure to a broad range of
chemical agents and physical stressors.
Q33. If a study reproducibly demonstrates the hormesis dose-response,
the implication for low doses would be the effects are:

Responses
Yes 34% (461)
No 66% (904)
Yes 10% (126)
No 90% (1201)
Yes 7% (92)
No 93% (1241)
Yes 25% (327)
No 75% (998)
(>60%)
(20-60%) (5-20%)
(1-5%)
(~0%)
Don’t
4% (60) 21%
29% (388) 18%
3%(47)
Know
(277)
(239)
25% (330)
(>60%)
(20-60%) (5-20%)
(1-5%)
(~0%)
Don’t
2%
13%
26%
23%
5%
Know
(28)
(176)
(345)
(303)
(67)
31% (418)
(>60%)
(20-60%) (5-20%)
(1-5%)
(~0%)
Don’t
4%
19%
21%
16%
5%
Know
(54)
(254)
(277)
(215)
(67)
35% (467)
(>60%)
(20-60%) (5-20%)
(1-5%)
(~0%)
Don’t
3%
14%
22%
17%
6%
Know
(36)
(188)
(290)
(230)
(87)
38% (500)
Does not occur
Not adequately
Is an exception
Not apply
2% (21)
studied
20% (240)
18% (220)
60% (715)
Agree
Disagree
14% (188)
86% (1159)
Agree
Disagree
64% (843)
36% (477)
Generally Agree
Generally Disagree
48% (584)
52% (633)
Likely Harmful
2% (20)

Beneficial or
Harmful
71% (937)

Likely
Beneficial
15% (203)

Not Likely to be
Significant
12% (155)

4.2.4.3 Knowledge and Opinions about Risk Assessment Principles and Practice
Section 5 consisted of eleven questions on risk assessment principles and practice.
This section contained three policy questions. The policy questions are examined first,
followed by the results of the remaining principles and practice questions.
Question 36 presented the statement “risk assessment procedures should be modified to
obtain potential benefits associated with hormesis.” The questions was also selected for
detailed comment analysis because it was thought this question might elicit the most
“passionate” response from subjects. The comments are summarized in a later section of
this Chapter.

A majority (68%) agreed that risk assessment procedures should be

modified to identify potential benefit. Question 38 was the third policy question and it
probed whether respondents would be willing to re-evaluate current regulations if the
hormesis dose-response was accepted as the default model for risk assessment. Seventyseven percent of respondents agreed that if hormesis were accepted as the default model
for risk assessment, regulations should be re- evaluated. The last policy question, number
39, stated “the phenomenon of hormesis justifies a change in hazard assessment protocols
(e.g. sample size, number of doses, timing of doses). A 65% majority agreed with this
statement. Further analyses of all the policy questions are presented in the univariate and
multivariate analysis of policy questions presented later in this chapter.
Although important in gaining an overall understanding of study respondent
knowledge and attitudes about risk assessment principles and practice, the remaining
questions did not undergo detailed analysis and are summarized in this section and
discussed in Chapter 5. Questions 34 and 35 asked about respondent attitudes toward
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chemical and ionizing radiation regulations. A majority (56%) thought current chemical
regulations were reasonable and a larger majority (78%) thought ionizing radiation
regulations were reasonable. In response to question 37, most (88%) thought hormesis
should be subjected to the traditional use of safety factors. The remaining questions
covered a variety of risk assessment topics. The responses to question 42 indicated 71%
think hormesis would not reduce the need for uncertainty factors. Responses to questions
40, 41, 43, and 44 indicate that most respondents generally agree that hormesis could
have a practical use in the conduct of risk assessment. The responses to all questions in
this section are summarized in Table 4.8.

4.3 Tests for Association
Chi-square tests, odds ratios, and multivariate logistic regression modeling were used to
identify characteristics of those who would accept or reject hormesis and to predict those
who would use hormesis in the conduct of risk assessments. This section provides an
examination of the four questions that were singled out for detailed analysis (questions
32, 36, 38 and 39). The selection criteria for each question are discussed in Chapter 3:
Methods. This section starts with an explanation of how variables were selected for
univariate analysis and then details the univariate and multivariate analysis results for
each question.
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Table 4.8: Summary statistics for Section 5 “Knowledge and Attitudes about Risk Assessment Principles and Practice”
Question
Q34. What is your perspective on the current state of chemical regulation?

Too Stringent
19% (239)
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Q35. What is your perspective on the current state of ionizing radiation regulations?

Too Stringent
13% (143)

Q36. Risk assessment procedures should be modified to obtain potential benefits associated
with hormesis.
Q37. If a chemical exhibits a hormesis dose-response, the risk assessment should
accommodate the data.
Q38. If hormesis were accepted as the default model for risk assessment, current
regulations should be re-evaluated.
Q39. The phenomenon of hormesis justifies a change in hazard assessment protocols (e.g.
sample size, number of doses, timing of doses).
Q40. Acceptance of hormesis decreases the margin of safety in risk assessments.

Generally Agree
59% (728)
Generally Agree
88% (1128)
Generally Agree
77% (950)
Agree
65% (797)
Generally Agree
29% (346)
Agree
62% (772)
Generally Agree
12% (152)
Generally Agree
64% (786)
Generally Agree
58% (663)

Q41. The J-shaped hormetic model shown in the figure indicates that at low doses risk of
disease is reduced.
Q42. If hormesis is present, the traditional use of safety factors or uncertainty factors is not
necessary.
Q43. If hormesis were accepted as the default model for risk assessment, current and past
risk assessment decisions should be formally re-evaluated.
Q44. Risk assessments based on the hormesis dose response could address chemical
mixtures as effectively as linear and threshold based risk assessments.

Responses
Reasonable
56% (698)

Not stringent
enough
25% (314)
Reasonable
Not stringent
78% (855)
enough
9% (103)
Generally Disagree
41% (517)
Generally Disagree
12% (163)
Generally Disagree
23% (285)
Disagree
35% (433)
Generally Disagree
71% (840)
Disagree
38% (467)
Generally Disagree
88% (1095)
Generally Disagree
36% (448)
Generally Disagree
42% (487)

4.3.1 Selection of Variables for Univariate and Multivariate Analysis
The chi-square test was calculated for all variables and all questions as described
in Chapter 3. The test results were exported to an Excel spreadsheet. This spreadsheet
was visually scanned to identify variables that consistently demonstrated heterogeneity
across multiple questions. Sixteen variables were identified as variables of interest based
on the chi-square screening analysis.
The demographic variables found to be statistically significant across most
questions were gender, highest attained degree, and society membership. An a priori
hypothesis that political, economic and social views would be predictive of those who
would accept or reject hormesis was not supported by the data. The variables
representing years of experience, subject age, nationality, and when a subject completed
the survey were not found to be potential indicators of acceptance or rejection of
hormesis.
Three broad employment categories were consistently significant: 1) employment
by a government regulatory agency, 2) employment in the private sector (industry) and 3)
employment in academia. The category government regulatory agency contained the US
Environmental Protection Agency (EPA) subset that was evaluated and consistently
found to be predictive of a lower acceptance rate, but not a rejection of hormesis as will
be explained later in this chapter. Three US government agencies showed a strong
acceptance of hormesis based on chi-square screening, Department of Energy,
Department of Defense, and the Food and Drug Administration but were not were not
carried forward as variables for detailed examination due to the low total number of
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subjects in each category (n<100). Subjects who worked for State government agencies
had a low acceptance rate for hormesis but were not carried forward, also due to low
numbers (n< 100). The industry category contained two employment subsets that were
significant and proved predictive of opinions toward hormesis; ever employed by the
pharmaceutical industry and ever employed in environmental consulting. The remaining
variables representing industry classifications were not significant. Note that respondents
could select multiple job categories. Most respondents selected one job category
(n=1,088). The remaining subjects selected none (n=27), two categories (n=201) or three
or more categories (n=147).
The specialty variables found to be statistically significant and with a sufficient
number of respondents (n>100) to carry forward in the analysis were general toxicology,
developmental and reproductive toxicology, inhalation toxicology, neurotoxicology,
regulatory policy, and risk assessment. The veterinary and ecology specialties were
consistently accepting of hormesis, but were not carried forward due to low numbers of
respondents (n<100). As with job categories, respondents were asked to select all
specialty categories that applied. Most subjects selected two categories (n=321),
followed closely by those that selected one category (n=315). Many respondents selected
three (n=288) and four (n=230) specialty categories.
Univariate odds ratios were calculated for each variable. Variables found to be
statistically significant were entered as covariates into the multivariate logistic regression
analysis.
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4.3.2 Univariate and Multivariate Analysis of Policy Questions

4.3.2.1 Univariate and Multivariate Analysis of Policy Question 32 About the
Widespread Applicability of the Hormesis Dose-Response Model
Question 32 specifically states “sufficient data exist to suggest hormesis occurs in
a wide range of species and endpoints following low-dose exposure to a broad range of
chemical agents and physical stressors.” The overall result was that 48% of respondents
agreed with the statement. The sixteen variables of interest were examined and the
results are shown in Table 4.9. Only two variables, women (OR=0.75, 95% CI=0.58,
0.96) and pharmaceutical industry employment (OR=0.59, 95% CI=0.42, 0.83) were
found to be significantly associated with the view of the widespread applicability of the
hormesis dose-response model, both in the direction of not subscribing to this view of
hormesis.
The two variables were entered as covariates in the logistic regression analysis
shown in Table 4.10. Both remained significantly associated after adjustment. Therefore,
the null hypotheses of no difference between male and female respondents, and no
difference between pharmaceutical workers and all other workers were rejected. Women
and respondents who were ever employed by the pharmaceutical industry are more likely
to disagree with question 32, that hormesis is common across species and endpoints.
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Table 4.9: Univariate analysis results for question 32 on the universality of the
hormesis dose-response
Variable

Agree
No.

Gender
Male
Female
Education
BS/MS
PhD, JD,MD,DVM
Society
SOT
SRA
Gov’t Reg. Agency
No
Yes
EPA Only
No
Yes
Ever EPA
No
Yes
Ever Industry
No
Yes
Ever Pharmaceutical
No
Yes
Ever Envron. Consult
No
Yes
Academic
No
Yes
General Toxicology
No
Yes
Devel/Reproductive
No
Yes
Inhalation Toxicology
No
Yes
Neurotoxicology
No
Yes
Regulatory Policy
No
Yes
Risk Assessment
No
Yes

%

Disagree
No.
%

Odds Ratio

95% CI1

P-Value

410
158

51
43

306
206

49
57

1.0
0.75

Reference
0.58, 0.96

0.024

114
459

48
48

124
495

52
52

1.0
1.0

Reference
0.75, 1.35

1.0

413
162

47
50

460
162

53
50

1.0
1.14

Reference
0.86, 1.44

0.445

467
108

49
46

494
128

51
54

1.0
0.89

Reference
0.66, 1.20

.479

552
23

48
41

589
33

52
59

1.0
0.75

Reference
0.41, 1.32

0.351

532
43

47
41

561
61

52
59

1.0
0.74

Reference
0.48, 1.14

0.184

291
284

49
47

301
321

51
53

1.0
0.91

Reference
0.72, 1.16

0.479

506
69

50
37

506
116

50
63

1.0
0.59

Reference
0.42, 0.83

0.001

507
68

47
55

566
56

53
45

1.0
1.36

Reference
0.93, 2.01

0.132

398
177

47
52

456
116

53
48

1.0
1.22

Reference
0.94, 1.58

0.133

233
342

50
47

231
391

50
53

1.0
0.87

Reference
0.68, 1.10

0.254

491
84

48
49

535
87

52
51

1.0
1.05

Reference
0.75, 1.47

0.822

508
67

48
56

543
79

34
35

1.0
0.91

Reference
0.63,1.30

0.642

508
67

48
50

554
68

52
50

1.0
1.07

Reference
0.76, 1.56

0.762

471
104

49
44

488
134

35
37

1.0
0.80

Reference
0.59, 1.08

0.154

299
276

48
48

323
299

33
37

1.0
1.0

Reference
0.78, 1.25

1.0

Abbreviations: CI, Confidence Interval; Gov’t Reg. Agency, government regulatory
agency; Envron, environmental; Devel, developmental
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Table 4.10: Multivariate logistic regression analysis results for question 32 on the
widespread applicability of the hormesis dose-response model
Covariate

Agree
No.
%

Gender
Male
Female
Ever Pharmaceutical
No
Yes

Disagree
No.
%

Univariate
Odds Ratio

Adjusted
Odds Ratio

95% CI1
Adjusted
OR

410
158

51
43

306
206

49
57

1.0
0.75

1.0
0.72

Reference
0.56, 0.93

506
69

50
37

506
116

50
63

1.0
0.59

1.0
0.58

Reference
0.42, 0.80

Abbreviations: CI, confidence interval; OR, odds ratio

4.3.2.2 Univariate and Multivariate Analysis of Policy Question 36 about Modifying
Risk Assessment Procedures to Include Potential Benefit
Question 36 specifically states “Risk assessment procedures should be modified
to obtain potential benefits associated with hormesis.” This question was designed to
evaluate whether respondents would accept modifying risk assessment procedures to
include potential benefit associated with hormesis. The overall result for this question
was 59% agreed procedures should be modified to include potential benefit. Additional
analysis was conducted to ascertain which respondents were most likely to agree. The
sixteen variable of interest were examined and the results are shown in Table 4.11. The
odds ratios and 95% CI indicated the following eight variables could be predictive of
acceptance or rejection: 1) highest degree attained; 2) employment by a government
regulatory agency; 3) being employed only by EPA; 4) being ever employed by EPA; 5)
employment in the private sector (industry); 6) employment as an environmental
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Table 4.11: Univariate analysis for question 36 about modifying risk assessment
procedures to obtain benefit from hormesis
Variable
Gender
Male
Female
Education
BS/MS
PhD, JD,MD,DVM
Society
SOT
SRA
Gov’t Reg. Agency
No
Yes
EPA Only
No
Yes
Ever EPA
No
Yes
Ever Industry
No
Yes
Ever Pharmaceutical
No
Yes
Ever Envron. Consult
No
Yes
Academic
No
Yes
General Toxicology
No
Yes
Devel/Reproductive
No
Yes
Inhalation Toxicology
No
Yes
Neurotoxicology
No
Yes
Regulatory Policy
No
Yes
Risk Assessment
No
Yes

Odds Ratio

95% CI1

P-Value

41
41

1.0
0.99

Reference
0.76, 1.28

0.976

86
417

34
43

1.0
0.67

Reference
0.49, 0.90

0.008

58
61

370
134

43
39

1.0
1.14

Reference
0.88, 1.43

0.336

597
117

61
49

381
123

39
51

1.0
0.61

Reference
0.45, 0.81

0.0007

695
19

60
32

464
40

40
68

1.0
0.32

Reference
0.17, 0.57

<0.0001

666
48

60
44

442
62

40
56

1.0
0.51

Reference
0.34, 0.78

0.001

341
373

56
62

273
231

44
38

1.0
1.29

Reference
1.03, 1.64

0.032

605
109

58
60

430
74

42
40

1.0
1.04

Reference
0.75, 1.46

0.844

629
85

58
67

463
41

42
33

1.0
1.56

Reference
1.02, 2.32

0.04

499
215

58
60

359
145

42
40

1.0
1.07

Reference
0.82, 1.38

0.659

299
418

61
57

192
312

39
43

1.0
0.85

Reference
0.67, 1.29

0.20

627
87

60
51

421
83

40
49

1.0
0.70

Reference
0.50, 0.99

0.04

636
78

59
53

435
69

41
47

1.0
0.78

Reference
0.55, 1.12

0.171

649
65

60
47

431
73

40
53

1.0
0.59

Reference
0.41, 0.86

0.005

568
146

58
61

409
95

42
39

1.0
1.11

Reference
0.82, 1.49

0.154

367
347

58
59

264
240

42
41

1.0
1.04

Reference
0.82, 1.31

0.780

Agree
No.

Disagree
No.
%

%

490
213

59
59

341
150

167
543

66
57

505
209

Abbreviations: CI, Confidence Interval; Gov’t Reg. Agency, government regulatory
agency; Envron, environmental; Devel, developmental
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consultant; 7) specializing in developmental and reproductive toxicology; and 8)
specializing in neurotoxicology.
The variables representing employment in government regulatory agency,
EPA only, and Ever EPA were found to be highly correlated. The variable “Gov’t Reg.
Agency” was selected to carry forward in the multivariate logistic regression model
because the 95% CI was smaller and the total number of respondents was larger. The
variables ever employed industry and ever employed environmental consultant also found
to be statistically correlated. Ever employed industry was selected for the multivariate
logistic regression model because it had the narrowest 95% CI and the largest number of
respondents. In addition to the sixteen variables of interest, political, social and
economic views were identified by chi-square screening analysis to be statistically
significant for question 36. Univariate and multivariate analysis of political, social and
economic views was conducted to determine whether the variables were correlated, and if
so, select the variable that would be entered into the multivariate logistic regression
model. For this analysis the reference group was set as “conservative”. Based on the
results of the analysis the variable “political” had the most significant odds ratios (i.e.,
lowest significance level) after adjusting for the effects of the covariates social and
economic; thus was selected for the overall multivariate analysis of question 36. The
univariate and multivariate analysis of the covariates (political, social, and economic) are
summarized in Table 4.12.
Six variables were entered into the multivariate analysis. Four variables remained
significant when adjusted for the effects of the other covariates. The adjusted odds ratios
resulting from the multivariate logistic regression analysis are shown in table 4.13.
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Table 4.12: Univariate and multivariate analysis for political, social, and economic
variables for question 36 about modifying risk assessment procedures to obtain
benefit from hormesis
Variable

Agree
No.

Political
Conservative
Middle of the
Road
Liberal
Choose no
Response
Social
Conservative
Middle of the
Road
Liberal
Choose no
Response
Economic
Conservative
Middle of the
Road
Liberal
Choose no
Response

%

Disagree
No.
%

Odds
Ratio

95% CI
Univariate

Adjusted
Odds
Ratio

95% CI
Adjusted

108
315
243
45

67
62
53
54

54
192
215
39

33
38
47
46

1.0
0.82
0.56
0.58

Reference
0.56, 1.19
0.39, 0.82
0.34, 0.98

1.0
0.66
0.58
0.70

Reference
0.39, 1.12
0.32, 1.06
0.27, 1.75

94
295
280
40

61
65
54
53

59
160
243
36

39
35
46
47

1.0
1.15
0.72
0.70

Reference
0.79, 1.69
0.50, 1.04
0.40, 1.21

1.0
0.66
0.58
0.70

Reference
0.98, 2.76
0.67, 1.95
0.37, 3.76

195
349
126
37

64
59
53
51

109
245
111
36

36
41
47
49

1.0
0.79
0.63
0.57

Reference
0.60, 1.06
0.49, 0.90
0.34, 0.96

1.0
0.88
0.87
0.69

Reference
0.63, 1.24
0.56, 1.36
0.23, 2.12
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Table 4.13: Multivariate logistic regression analysis results for question 36 about
modifying risk assessment procedures to include benefit from hormesis
Covariate
Education
BS/MS
PhD, MD, JD, DVM
Gov’t Reg. Agency
No
Yes
Ever Industry
No
Yes
Develop/Reproductive
No
Yes
Neurotoxicology
No
Yes
Political
Conservative
Middle of the Road
Liberal
Choose no Response

Agree
No.
%

Disagree
No.
%

Univariate
Odds Ratio

Adjusted
Odds Ratio

95% CI
Adjusted
OR

167
543

66
57

86
417

34
43

1.0
0.67

1.0
0.68

Reference
0.51. 0.92

597
117

61
49

381
123

39
51

1.0
0.61

1.0
0.63

Reference
0.47, 0.85

341
373

56
62

273
231

44
38

1.0
1.29

1.0
1.09

Reference
0.86, 1.40

627
87

60
51

421
83

40
49

1.0
0.70

1.0
0.80

Reference
0.57, 1.12

649
65

60
47

431
73

40
53

1.0
0.59

1.0
0.67

Reference
0.46, 0.97

108
315
243
45

67
62
53
54

54
192
215
39

33
38
47
46

1.0
0.82
0.56
0.58

1.0
0.83
0.58
0.55

Reference
0.57, 1.21
0.40, 0.85
0.32, 0.96

Abbreviations: Gov’t Reg Agency, Government Regulatory Agency; OR, odds ratio

Respondents with the highest attained degree of PhD were in overall agreement
with modifying risk assessment to accommodate hormesis (57%) but were significantly
less likely to agree than respondents with bachelor and masters degrees (66%).
Respondents ever employed by a government regulatory agency were less likely
to accept a change to accommodate hormesis (49% agree). Employment by industry was
not a significant indicator when adjusted for the effects of the other covariates.
The specialty of developmental and reproductive toxicology was not a significant
predictor in the model. However, the specialty of neurotoxicology remained significant
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and subjects with this specialty were less likely to agree with changing risk assessment
procedures to evaluate potential benefit (47% agree).
Compared to political conservatives; respondents who had liberal views or chose
not to respond, were less likely to agree that risk assessment procedures should be
modified to obtain potential benefits associated with hormesis.
Question 36 was selected for detailed comment analysis because it was thought
that this question might elicit a “passionate” response about the respondent’s opinion of
hormesis. The question received 323 comments. Only questions, 16, 24, and 30 received
more comments. The comments were scored, positive, negative and neutral/explanation
of response. One comment was scored as positive, 23 responses were negative,
remaining responses were scored as neutral because the respondent was simply
explaining his/her choice for agreeing or disagreeing or providing suggestions for
improving clarity and meaning of the question. Negative comments tended to focus on
two themes; perceived dangers in including an analysis of benefit and creation of an
“industry loophole.” Neutral comments were directed to the need for conclusive data
supporting benefit. If the respondent agreed with question 36, the comment indicated
more data were needed. If the respondent disagreed, the comment was a caveat that
agreement depended on sufficient conclusive data. The implications of the comments are
explored further in Chapter 5: Discussion.
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4.3.2.3 Univariate and Multivariate Analysis of Policy Question 38 about ReEvaluating Regulations if Hormesis Were the Default Model
The question specifically states “If hormesis were accepted as the default model
for risk assessment, current regulations should be re-evaluated.” Many of the current
government regulations are based on default dose-response models; linear-non threshold
for carcinogenic compounds and threshold for all other potential toxicants. This question
requests the respondent to consider a situation in which the regulatory default was the
hormesis dose-response and asks whether regulations should be re-evaluated. The overall
result for this question was that 77% of respondents agreed regulations should be reevaluated.
Four variables met the criteria for statistical significance: 1) highest attained
degree 2) ever employed by a government regulatory agency 3) employed only by EPA
and 4) ever employed by EPA. The variables representing employment in government
regulatory agency, EPA only, and Ever EPA were found to be highly correlated. The
variable “Gov’t Reg. Agency” was selected to carry forward in the multivariate logistic
regression model because the 95% CI was narrower in the univariate analysis and the
total number of respondents was larger. Results of the univariate analysis on the
variables of interest are presented in Table 4.14.
Highest attained degree and ever employed by a government regulatory agency,
were entered as covariates in a logistic regression analysis. The two covariates remained
significant when adjusted for the effects of one another. Although 76% of respondents
with PhD’s agreed that current regulations should be re-evaluated if hormesis were
accepted as the default risk assessment model, they were significantly less likely to agree
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Table 4.14: Univariate analysis results for question 38 about re-evaluating
regulations if hormesis were the default model
Variable

Agree
No.

Gender
Male
Female
Education
BS/MS
PhD, JD,MD,DVM
Society
SOT
SRA
Gov’t Reg. Agency
No
Yes
EPA Only
No
Yes
Ever EPA
No
Yes
Ever Industry
No
Yes
Ever Pharmaceutical
No
Yes
Ever Envron. Consult
No
Yes
Academic
No
Yes
General Toxicology
No
Yes
Devel/Reproductive
No
Yes
Inhalation Toxicology
No
Yes
Neurotoxicology
No
Yes
Regulatory Policy
No
Yes
Risk Assessment
No
Yes

%

Disagree
No.
%

Odds Ratio

95% CI

P-Value

636
283

77
79

193
73

23
21

1.0
1.18

Reference
0.86, 1.62

0.33

204
724

83
76

42
230

17
24

1.0
0.65

Reference
0.44, 0.94

0.021

668
265

76
80

207
65

24
20

1.0
1.26

Reference
0.92, 1.76

0.163

769
164

79
69

200
72

21
31

1.0
0.59

Reference
0.43, 0.83

0.002

901
35

78
58

249
23

22
42

1.0
0.42

Reference
0.24, 0.76

0.004

867
66

79
63

234
38

21
37

1.0
0.47

Reference
0.30, 0.74

0.001

458
475

76
78

141
131

24
22

1.0
1.12

Reference
0.84, 1.48

0.466

799
134

78
73

223
49

22
27

1.0
0.76

Reference
0.53, 1.12

0.170

826
107

77
84

252
20

23
16

1.0
1.63

Reference
0.98, 2.84

0.06

660
268

77
78

197
75

23
22

1.0
1.07

Reference
0.78, 1.46

0.735

384
549

80
76

95
177

20
24

1.0
0.77

Reference
0.57, 1.02

0.07

805
128

78
74

228
44

22
26

1.0
0.82

Reference
0.56, 1.23

0.356

826
107

78
71

229
43

22
29

1.0
0.69

Reference
0.46, 1.04

0.075

832
102

78
76

240
32

22
24

1.0
0.91

Reference
0.59, 1.44

0.73

753
180

77
78

220
52

23
22

1.0
1.01

Reference
0.72, 1.45

1.0

483
450

77
78

143
129

23
22

1.0
1.03

Reference
0.78, 1.37

0.87

Abbreviations: CI, Confidence Interval; Gov’t Reg. Agency, government regulatory
agency; Envron, environmental; Devel, developmental
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than respondents with bachelor and masters degrees. The result for was similar for
respondents ever employed by a government regulatory agency (69 vs.79%). The
adjusted odds ratios are presented in Table 4.15.

Table 4.15: Multivariate logistic regression results for question 38 about reevaluating regulations if hormesis were the default model
Covariate

Agree
No.

Education
BS/MS
PhD, JD, MD,
DVM
Gov’t Reg. Agency
No
Yes

%

Disagree
No.
%

Univariate
Odds Ratio

Adjusted
Odds Ratio

95% CI
Adjusted OR

204
724

83
76

42
230

17
24

1.0
0.65

1.0
0.64

Reference
0.44, 0.92

769
164

79
69

200
72

21
31

1.0
0.59

1.0
0.59

Reference
0.43, 0.81

Abbreviations: Gov’t Reg. Agency, government regulatory agency; OR, odds ratio

4.3.2.4 Univariate and Multivariate Analysis of Policy Question 39 about Modifying
Hazard Assessment to Accommodate the Phenomenon of Hormesis
The question specifically states “The phenomenon of hormesis justifies a change
in hazard assessment protocols (e.g. sample size, number of doses, timing of doses).”
The overall result was that 65% of respondents agreed with the statement. This is
an important indicator as to whether researchers would accept changing hazard
assessment design including sample size, timing and number of doses in order to reliably
detect a hormetic dose-response.
Eight variables met the criteria for statistical significance: 1) being a woman; 2)
employment by a government regulatory agency; 3) employment only by EPA; 4)
employment in the pharmaceutical industry; 5) employment as an environmental
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Table 4.16: Univariate analysis results for question 39 about modifying hazard
assessment to accommodate hormesis
Variable

Agree
No.

Gender
Male
Female
Education
BS/MS
PhD, JD,MD,DVM
Society
SOT
SRA
Gov’t Reg. Agency
No
Yes
EPA Only
No
Yes
Ever EPA
No
Yes
Ever Industry
No
Yes
Ever Pharmaceutical
No
Yes
Ever Envron. Consult
No
Yes
Academic
No
Yes
General Toxicology
No
Yes
Devel/Reproductive
No
Yes
Inhalation Toxicology
No
Yes
Neurotoxicology
No
Yes
Regulatory Policy
No
Yes
Risk Assessment
No
Yes

%

Disagree
No.
%

Odds Ratio

95% CI

P-Value

518
255

63
72

306
101

37
28

1.0
1.49

Reference
1.13, 1.98

0.004

175
603

70
64

76
342

30
36

1.0
0.76

Reference
0.56, 1.04

0.093

562
219

64
67

312
108

36
33

1.0
1.13

Reference
0.85, 1.49

0.427

650
131

67
57

320
100

33
43

1.0
0.65

Reference
0.48, 0.87

.004

755
26

60
48

392
28

34
52

1.0
0.48

Reference
0.27, 0.87

0.01

722
59

66
58

377
43

34
42

1.0
0.72

Reference
0.47, 1.11

0.141

395
386

66
64

200
220

34
36

1.0
0.89

Reference
0.70, 1.13

0.359

686
95

67
52

332
88

33
48

1.0
0.52

Reference
0.38, 0.73

<0.0001

682
99

63
79

394
26

37
21

1.0
2.20

Reference
1.39, 3.59

0.0004

537
244

63
71

318
102

37
29

1.0
1.42

Reference
1.07, 1.87

0.013

327
454

69
62

145
275

31
38

1.0
0.73

Reference
0.57, 0.94

0.015

667
114

65
67

363
57

35
33

1.0
1.01

Reference
0.76, 1.56

0.69

699
82

66
55

354
66

34
35

1.0
0.63

Reference
0.44, 0.91

0.012

691
90

65
67

375
45

35
33

1.0
1.08

Reference
0.73, 1.62

0.748

633
148

65
63

334
86

35
37

1.0
0.91

Reference
0.67, 1.24

0.573

413
368

67
63

205
215

33
37

1.0
0.85

Reference
0.66, 1.08

0.198

Abbreviations: CI, Confidence Interval; Gov’t Reg. Agency, government regulatory
agency; Envron, environmental; Devel, developmental
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consultant; 6) employment in academia; 7) specializing in general toxicology; and 8)
specializing inhalation toxicology. Odds ratios and 95% confidence intervals for all
variables are presented in Table 4.16.
Because half the variables were statistically significant and potential indicators of
who accept modifying hazard assessment to accommodate hormesis, the variables were
tested for correlation using step-wise logistic regression analysis. The variable ever
employed by a government regulatory agency was selected for the multivariate logistic
regression over the EPA subsets because the confidence interval was narrower and the
total number of respondents was larger. Correlation testing indicated the remaining
variables were not correlated and all were entered into the multivariate analysis.
Seven variables were entered into the multivariate logistic regression model. Five
variables remained significant after adjusting for the effects of covariates. Women were
more likely than men to agree with changing hazard assessment protocols (72 vs.63%).
Respondents that were ever employed as environmental consultants were more likely to
agree when compared to all other employment categories (79 vs. 63%). Respondents
ever employed by a government regulatory agency (57%) or ever employed by a
pharmaceutical company (52%) were less likely to agree with changing hazard
assessment protocols as compared to all other employment categories. Respondents with
the specialty of inhalation toxicology were less likely to agree to changes in hazard
assessment protocols than all other specialties (55%). The variables “ever employed in an
academic setting” and “specialty general toxicology” were no longer significant when
adjusted for the effects of the other covariates. The adjusted odds ratios are provided in
Table 4.17.
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Table 4.17: Multivariate analysis results for question 39 about modifying hazard
assessment to accommodate hormesis
Covariate

Agree
No.

Gender
Male
Female
Gov’t Reg. Agency
No
Yes
Ever Pharmaceutical
No
Yes
Ever Envron. Consult
No
Yes
Inhalation
Toxicology
No
Yes

%

Disagree
No.
%

Univariate
Odds Ratio

Adjusted
Odds Ratio

95% CI
Adjusted OR

518
255

63
72

306
101

37
28

1.0
1.49

1.0
1.44

Reference
1.09, 1.90

650
131

67
57

320
100

33
43

1.0
0.65

1.0
0.61

Reference
0.44, 0.83

686
95

67
52

332
88

33
48

1.0
0.52

1.0
0.58

Reference
0.41, 0.82

682
99

63
79

394
26

37
21

1.0
2.20

1.0
2.11

Reference
1.32, 3.37

699
82

66
55

354
66

34
35

1.0
0.63

1.0
0.64

Reference
0.45, 0.92

Abbreviations: CI, Confidence Interval; Gov’t Reg. Agency, government regulatory
agency; Envron, environmental; OR, odds ratio

4.3.2.5 Evaluation of Question 26 about Respondents’ Actual Observations of
Hormetic Dose-Response on Response to the Four Policy Questions
Question 26 asks respondents about their dose-response research observations.
The purpose of evaluating this question was to determine whether first-hand observation
of a hormetic dose-response effect, affects respondents attitudes toward hormesis. Of
the approximately 1,100 respondents with direct research experience observing biological
responses, approximately half (n=555) reported direct experience observing a hormetic
dose-response either commonly or occasionally. The results are provided in Table 4.18.
The 555 respondents who commonly or occasionally observed biological
responses that best fit the hormesis dose response were evaluated to determine whether
their opinions on the policy questions differed from their colleagues who rarely or never
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Table 4.18: Data on respondents who reported observing biological responses that
best fit the threshold, linear non-threshold, and hormetic dose-response models
Q26: In my
research
biological
responses that
best fit the
following model
are:
Hormesis
LNT
Threshold

Common
No.

%

No.

127
237
759

12
22
68

428
392
260

Occasional
%

Rare

39
36
23

Never

No.

%

No.

%

366
309
63

34
28
6

171
153
39

16
14
3

Abbreviations: LNT, linear non-threshold
observed hormesis. This group with direct experience observing a hormetic doseresponse had a tendency to agree with the policy questions that favor hormesis, whereas
those who had rare to no personal research experience observing a hormetic doseresponse were less likely to favor hormesis, except for question 38 on hormesis as the
default model. The results are provided in Table 4.19.

Table 4.19: Results for respondents who observed hormesis commonly, occasionally,
rarely or never vis-a-vis the four policy questions
In my research hormesis
dose response
is observed:
Commonly
Occasionally
Rarely
Never

Q321
General
% Agree
79
58
31
31

Q362
Benefit
% Agree
75
65
50
42

Q383
Default
% Agree
82
81
74
65

Q394
Dosing
% Agree
81
73
54
57

1. Q32 Sufficient data exist to suggest hormesis occurs in a wide range of species and endpoints following
low-dose exposure to a broad range of chemical agents and physical stressors.
2. Q36 Risk assessment procedures should be modified to obtain potential benefits associated with
hormesis.
3. Q38 If hormesis were accepted as the default model for risk assessment, current regulations should be reevaluated.
4. Q39 The phenomenon of hormesis justifies a change in hazard assessment protocols (e.g. sample size,
number of doses, timing of doses).
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4.4 Internal Consistency Analysis
Two tests for internal consistency were built into the questionnaire. Chronbach’s
coefficient alpha was used as the statistical measure of internal reliability. This statistic
tests whether the survey elicits consistent and reliable responses between questions
designed to ask related questions that have similar responses. The Alpha coefficient
ranges between 0 and 1, with higher scores indicating greater internal consistency.
For this survey, if a person disagreed with question 15 “Regulatory upper-bound
characterizations used in cancer risk assessments provide accurate estimates of the
probability of developing cancer” they were thought to be likely to answer agree to
question 19 “the linear model employed in cancer risk assessment overstates risk in the
low dose zone” because both questions evaluate the respondents opinion on the current
dose-response default model for cancer risk assessment. The result was 0.24, indicating
a moderately low consistency in responses.
The second test was between questions 31 and 41. Question 31 states “if a study
reliably shows a J-shaped dose response curve, it implies low dose effects could be
beneficial.” Question 41 makes essentially the same statement “the J-shaped hormetic
model shown in the figure indicates that at low doses risk of disease is reduced.” The
Chronbach’s alpha coefficient for this comparison was 0.51.

4.5 Evaluation of Response Bias
The purpose of this section is to address concerns that those who responded to the
survey differed from those who did not. The first step of the evaluation was conducted
by analyzing responses between those who completed the survey and those who did not.
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Then auxiliary information provided by the SOT on membership characteristics was used
to compare with SOT study respondents to identify whether large differences existed
between society membership as a whole and study respondents. Additional information
was provided by researchers conducting a similar survey shortly after the current survey,
which was used to further examine potential for response bias. Finally, coded comments
were evaluated.

4.5.1 Comparisons of Subjects who Completed the Questionnaire to Subjects who
Did Not
In order to address concerns about response bias the characteristics of those who
completed the survey were compared to those who started the survey, but dropped out
along the way. The null hypothesis tested was that there was no difference between those
who started and those who completed.
The sixteen variables evaluated for the four policy questions were also evaluated
for this analysis. The only variables that were statistically significant were 1) being a
member of the Society for Risk Analysis and 2) selecting “choose not to respond” as an
answer to the social, economic, and political views questions. These results are
discussed further in Chapter 5. Analytical results for the sixteen variables of interest plus
social, economic, and political views are shown in Tables 4.20 and 4.21.
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Table 4.20: Univariate analysis of sixteen variables tested for policy questions
comparing respondents who completed the questionnaire (answered Q43) to
respondents who dropped out in Sections 3, 4, or 5
Variable
Gender
Male
Female
Education
BS/MS
PhD, JD,MD,DVM
Society
SOT
SRA
Gov’t Reg. Agency
No
Yes
EPA Only
No
Yes
Ever EPA
No
Yes
Ever Industry
No
Yes
Ever Pharmaceutical
No
Yes
Ever Envron. Consult
No
Yes
Academic
No
Yes
General Toxicology
No
Yes
Devel/Reproductive
No
Yes
Inhalation Toxicology
No
Yes
Neurotoxicology
No
Yes
Regulatory Policy
No
Yes
Risk Assessment
No
Yes

Dropped
No.
%

Completed
No.
%

Odds Ratio

95% CI1

P-Value

167
93

17
21

816
354

83
79

1.0
1.3

Reference
0.96, 1.79

0.08

68
201

22
18

242
945

78
82

1.0
0.75

Reference
0.56, 1.03

0.07

175
96

17
23

870
322

83
77

1.0
1.48

Reference
1.12, 1.96

0.005

210
61

18
21

956
227

82
79

1.0
1.23

Reference
0.90, 1.70

.19

254
17

18
24

1139
53

82
76

1.0
1.44

Reference
0.82, 2.53

0.20

245
26

18
20

1089
103

82
80

1.0
1.12

Reference
0.71, 1.76

0.62

142
129

19
18

589
603

81
82

1.0
1.29

Reference
0.91, 1.81

0.10

220
51

18
22

1010
182

82
78

1.0
1.29

Reference
0.91, 1.81

0.37

251
20

19
14

1065
127

81
86

1.0
0.67

Reference
0.41, 1.10

0.11

199
72

19
18

855
337

81
82

1.0
0.92

Reference
0.68, 1.23

0.57

115
156

19
18

478
714

81
82

1.0
0.91

Reference
0.69, 1.19

0.48

239
32

19
16

1019
173

81
84

1.0
0.79

Reference
0.53, 1.18

0.24

242
29

19
17

1048
144

81
83

1.0
0.87

Reference
0.57,1.33

0.52

242
29

19
18

1057
135

81
82

1.0
0.94

Reference
0.61, 1.43

0.23

214
57

18
19

955
237

82
81

1.0
0.96

Reference
0.74, 1.25

0.67

143
128

19
18

616
576

81
82

1.0
0.96

Reference
0.74, 1.25

0.75

Abbreviations: CI, Confidence Interval; Gov’t Reg. Agency, government regulatory
agency; Envron, environmental; Devel, developmental
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Table 4.21: Univariate analysis of political, social, and economic variables
comparing respondents who completed the questionnaire (answered Q43) to
respondents who dropped out in Sections 3, 4, or 5
Variable

Dropped
No.
%

Political
Conservative
Middle of the Road
Liberal
Choose no Response
Social
Conservative
Middle of the Road
Liberal
Choose no Response
Economic
Conservative
Middle of the Road
Liberal
Choose no Response

Completed
No.
%

Odds Ratio

95% CI

26
93
115
35

14
16
21
30

163
502
439
80

86
84
79
70

1.0
0.86
0.61
0.37

Reference
0.54, 1.37
0.38, 0.97
0.21, 0.65

24
95
114
34

14
17
18
33

149
452
512
69

86
83
82
67

1.0
0.76
0.72
0.33

Reference
0.47, 1.24
0.45, 1.16
0.18, 0.59

50
135
50
32

14
19
18
33

305
585
228
64

86
81
82
67

1.0
0.71
0.75
0.33

Reference
0.50, 1.01
0.48, 1.47
0.19, 0.55

4.5.2 SOT Demographic Comparison
External validity is achieved in part by in assessing whether respondents’
characteristics reflect the characteristics of the society membership as a whole. The
Society of Toxicology provided general demographic information on its membership that
was used to compare to those who responded to the survey. The bar graphs in Figures
4.6, 4.7, and 4.8 indicate the SOT study respondents closely match the society
membership.
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Figure 4.6: Bar chart showing gender and years of experience similarities between
the SOT membership and SOT study respondents

Figure 4.7: Bar chart showing educational similarities between the SOT
membership and SOT study respondents

74

Figure 4.8: Bar chart showing employment similarities between SOT membership
and SOT study respondents

4.5.3 Comparisons with Survey Information from a Similar Study of SOT
Less than three months after the Hormesis Knowledge and Opinions survey was
administered to the Society of Toxicology membership, George Mason University in
conjunction with the Society of Toxicology administered a census survey to those who
were listed as full members of SOT to ascertain their opinions about specific chemical
risks. The researchers distributed an online questionnaire toall 3,562 full members of the
SOT. The survey was open from January 27 through March 2, 2009. They had a return
rate of 32%. Over 200 people dropped the survey after completing the demographic
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section for an adjusted response rate of 26%. Their overall findings were based on
responses of the 937 who continued after the demographic section. The George Mason
researchers kindly provided their demographic data to this investigator for comparison.
Unlike the George Mason survey, the Hormesis survey was distributed to all SOT
members, including students. In order to make similar comparisons, the student members
and members with < 5 years of experience (representing associate members) were
dropped from the hormesis survey. Overall the two surveys are remarkably similar on
most criteria as shown in Figures 4.9, 4.10, 4.11. Comparisons for gender, age and
regional demographics are virtually identical (Figures 4.9, 4.10). The areas of
employment do not match exactly but are similar. The lack of an exact match may be
because the hormesis survey respondent was able to check all the employment types and
specialties that applied, whereas the George Mason/SOT survey respondents were
restricted to selecting one category that best described the respondent.
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Figure 4.9: Comparison of the George Mason survey demographic data with the
Hormesis Survey demographics

Figure 4.10 Comparison of the George Mason survey regional representation with
the Hormesis Survey respondents
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Figure 4.11: Comparison of the George Mason survey employment areas with the
Hormesis Survey respondents

4.5.4 Evaluation of Responses
The research committee suggested coding comments to Questions 36, 45 and 46
as to whether they were negative, neutral, or positive toward hormesis in an effort to
indirectly evaluate response bias. The results are summarized in Figure 4.12. For the
purposes of this study, if comments were overwhelmingly positive or negative, over 20%
in either direction, it was concluded response bias could be present. If however, the
overwhelming majority of comments, 80%, were neutral then it was concluded response
bias may be low. For question 36 only 7% of responses were coded as negative. This is
a significant result because this question, above all others was predicted to elicit a
negative response. A discussion of some of the more interesting responses is included in
Chapter 5. Question 45 was a request for comments about content that may have been
missed, 81% of comments were coded neutral, 11% were negative, and 8% were positive.
Eleven of the 38 negative comments indicated the respondent thought the survey was
biased to favor hormesis. Question 46 was a request for information about what could
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Figure 4.12: Positive, neutral and negative comments of questions 36, 45 and
46 indicating that most comments were neutral, meaning they were informative
rather than critical

have been done to make the survey better. 81% were coded neutral, 12% were negative,
and 7% were positive. Nine of the 39 negative comments indicated the respondent
thought the survey was biased toward hormesis. For both questions 45 and 46,
approximately 10% of the neutral comments were suggestions to use Likert-type rating
scale rather than the dichotomous scale employed in the survey.
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CHAPTER 5
DISCUSSION

5.1 Introduction
The goals of this first-ever survey of the acceptance and understanding of the
hormesis dose-response concept among toxicologists and risk assessors were to ascertain
attitudes on hormesis and other dose-response models; and to identify how the level of
acceptance or rejection of hormesis is related to knowledge of or experience with
hormesis, predisposing values, or demographic characteristics. This chapter begins with
a discussion of the major findings related to the research goals, followed by a discussion
of study limitations.

5.2 Major Findings
A primary rationale for this study was to determine whether toxicologists and risk
assessors believe that hormesis commonly occurs across biological systems, endpoints,
and chemical classes as has been reported in reviews of the literature (Anderson, 2005;
Calabrese and Baldwin 2001a,d; Calabrese and Blain, 2005; Cook and Calabrese, 2006
a); or whether the survey respondents believe that hormesis dose-response is a rare event
(Mushak, 2007; Thayer et al., 2005). Contrary to expectation, 50% of the respondents
indicated they believe sufficient data presently exist to support the view that hormesis
occurs across a wide range of species and endpoints. The fact that half of the respondents
accept the broad generalizability of hormesis is notable because, aside from the
published literature, hormesis is ignored or rejected outright by regulatory agencies
(USEAP, 2004). The survey further indicates that most respondents have not taken
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advantage of the few training opportunities available for hormesis; 90% of respondents
indicated they never attended a hormesis workshop and 93% indicated they had never
attended a conference on hormesis. Furthermore, 75% had never received any classroom
instruction on the topic.
The finding is even more striking when one considers not just small number of
respondents attending learning opportunities, but also the relative lack until recently of
published studies reporting a hormesis dose-response. It is possible that the proliferation
of recent publications may have had an impact on respondent opinions on the
generalizability of hormesis. A search of the Web of Science ® database shows that
citations of the keywords hormesis or hormetic occurred at approximately 15 per year
throughout the decade of the 1980’s, then in the 1990’s the citation rate slowly increased,
ending the decade with a total of 200 citations for the year 1999. Citations increased
rapidly in the current decade and finally doubled from 1,100 citations in 2006 to over
2,200 in 2008.
Interestingly, characteristics of the respondents such as: years of experience, the
society of membership, level of education, place of residence, most types of employment
(excluding government and pharmaceutical companies), and political, economic or social
views did not have a direct influence on their opinion on the broad generalizability of
hormesis.
One of the largest influences on willingness to take hormesis into consideration as
a valid biological model of dose-response was experience with hormesis based on actual
research. Seventy-nine percent of subjects who reported observing the hormesis doseresponse commonly in their studies agreed with the statement that hormesis is broadly
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generalizable across multiple species and biological endpoints. Indeed, commonly or
occasionally observing hormesis in one’s own research had a profoundly positive impact
on respondent’s opinions on all of the policy questions.
Only two groups of respondents were found to be statistically significantly less
supportive of the statement that hormesis occurs widely across species and endpoints:
women (43% agreed) and those employed by the pharmaceutical industry (37% agreed).
The variables were tested for correlation and were found to be independent and not
correlated with any other variable, including social and political leanings. The openended comments made by women (n=42) indicated they did not reject the concept of
hormesis per se, but thought sufficient data do not exist to support broad generalizability
at this time.
The finding that only 37% of those employed by pharmaceutical companies
agreed that hormesis occurred across the broad biological spectrum was unexpected.
Indeed, prior to the study, it was hypothesized that this group would be much more likely
to subscribe to the view that hormesis is common across multiple species and endpoints.
This a priori assumption was made because much of the dose-response data in the
published literature are derived from studies of pharmaceutical agents (Calabrese and
Blain, 2005). Additionally, two issues of the journal Critical Reviews in Toxicology
(McClellan, 2001, 2008) dedicated to hormesis present the results of a large number of
pharmaceutical research studies demonstrating the hormesis dose-response. Because the
finding was unexpected the comments were evaluated. Among the open-ended
comments of those who disagreed (n=18), most stated that although hormesis is
frequently detected in pharmaceutical research, the studies are not sufficient to support

82

the view that hormesis occurs in all species and biological responses across multiple
agents and stressors.
Ironically, strong support for including an evaluation of public health benefit was
shown by those employed by the pharmaceutical industry (60%). This high level of
support is an interesting juxtaposition to the group’s seeming rejection of the statement
that hormesis is broadly generalizable. However, this may be explained when one
considers the objective of drug discovery is to evaluate multiple doses in a more or less
linear fashion of promising formulations in order to identify the beneficial zone for
therapeutic impact, while at the same time establishing drug safety by identifying adverse
reactions, which are typically dose-related. Simply put, drug discovery is to promote
successful treatment while minimizing harm. The fact that benefit or harm may occur at
low doses is clearly important to this group.
Despite the fact that EPA (2004) has explicitly excluded from risk assessment the
analysis of public health benefit associated with low-dose exposure, 59% of respondents
indicated that the potential for hormesis benefit should be included in a risk assessment.
These findings suggest that toxicologists and risk assessors are willing to consider
biological realities rather than conventional mathematic models such as the linear or
threshold.
Support for including an analysis of benefit was found across most of the
surveyed population. The only group that strongly disagreed (68%) with evaluating
potential for public health benefit was EPA employees. This suggests that EPA policy
may have biased their views, or that the institutional structure in place has reduced the
range of acceptable thought within the agency.
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Strong desire on the part of a majority of respondents (59%) to modify risk
assessment in order to evaluate potential benefits at low doses may indicate that
respondents would welcome the opportunity to analyze multiple dose response curves
instead of forcing the data to fit default models that may or may not represent the
biological reality. Groups strongly supportive of the ability to consider benefit (60% or
greater agree) were academics, those employed by industry, members of the Society for
Risk Analysis, political and social conservatives and moderates , environmental and
toxicological consultants, pharmacologists and regulatory policy specialists.
The only group other than government regulatory agencies, specifically EPA, in
disagreement with changing risk assessment procedures to examine potential public
health benefit from hormesis was the group identifying with a specialty of
neurotoxicology. 47% of respondents in this group agreed with modifying risk
assessment to identify benefits. This finding appears to be unusual given the general
finding that the hormesis dose-response not only dominates the field of neuroscience
research but is the basis for many therapeutic agents for neurodegenerative diseases.
Many of the therapeutic agents for these diseases rely on a beneficial low-dose
stimulatory response (Diamond, 2008; Kastin and Pan, 2008; Mattson, 2008). An
explanation may be found in the fact that neuroscience studies rarely report findings as
hormesis; instead the researchers rely on a variety of dose-response descriptions
including U-shaped, bell curve, biphasic, bitonic, and others (Calabrese, 2008).
Researchers could simply be unaware of the concept of hormesis as it relates to their
study results. Alternatively, respondents may be employing a cautious self-revisionist
epistemic approach to hormesis as suggested by some neuroscience experts (Giordano et
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al., 2008). The open ended comments provided by neurotoxicologists who disagree with
including an analysis of benefit in risk assessment (n= 32) indicate that the explanations
proposed by both Calabrese (2008) and Giordano et al. (2008) may be true. Most
indicated biological systems were too variable and therefore incorporation of benefit was
not warranted, others indicated they selected to disagree because not enough data existed,
while a few indicated they did not completely understand the utility of hormesis for
determining benefit or harm.
In fact, the rest of the open ended comments about the concept of incorporating
hormesis into risk assessment followed the tenor of responses from the
neurotoxicologists. None of the comments espoused passionate or extremely negative
opinions about hormesis as expected. The vast majority (93%) of those providing
comments about the concept of benefit were explaining their answers and they too tended
to focus on population variation, the desire for more data, or the desire to know more
about hormesis before agreeing. The few negative responses focused on perceived
dangers of assuming benefit and concern about the creation of an “industry loophole.”
However, none of the comments was passionately for or against the concept which
indicates that most toxicologists and risk assessors are seeking a rational, data-driven
approach to risk assessment that incorporates all available data and is sensitive to
biological complexity.
The finding of support for evaluating benefit is validated by the finding that a
majority of all respondents (65%) are in favor of modifying hazard assessment protocols
to identify the presence of hormesis. This opinion was held across all sectors, regardless
of demographic characteristic, years of experience, employment history, politic, social, or
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economic views, or any other characteristic. Even those employed by government
regulatory agencies and neurotoxicologists who were against applying hormesis to obtain
a public health benefit were in favor of designing studies that could identify the presence
of the hormesis phenomenon. In particular, neurotoxicologists are strongly (67%) in
favor of modifying study designs to identify whether the hormesis dose-response is
present.
Because all groups agreed (93%) on the definition of hormesis that states the
dose-response exhibits biological responses at low doses that are opposite to those
observed at high doses and because all groups agree hormesis could be either beneficial
or harmful (71%) it is consistent that such a large majority (65%) would be supportive of
modifying dose-response studies (sample size, number and timing of doses) to determine
whether hormesis was present. In addition, support for modifying dose-response
assessments to identify hormesis has been expressed by a variety of researchers
representing diverse areas of specialty. The scientists state that research efforts should be
redirected from looking only at adverse effects at high doses and adjusted to be able to
identify whether adverse or beneficial biological effects are occurring at heretofore
unstudied lower doses (Kastin and Pan, 2008; Stumpf, 2006; Thong and Maibach, 2007).
Indeed, the support for modifying dose-response study designs suggest that respondents
are interested in conducting thorough dose-response assessments capable of clearly
delineating the true shape of the dose response.
The final major result is that 75% of respondents indicated current regulations
should be re-evaluated if hormesis were accepted as the default model for risk
assessment. Not surprisingly, subjects who were ever employed by a government
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regulatory agency were somewhat less likely to agree (69%) but, 69% is still a large
majority of the group. Although this was a hypothetical question, using the word “if” as
a request for the respondent to speculate, a very specific conclusion can be drawn from
the response: toxicologists and risk assessors appear to be willing to reexamine their
research methods, and study designs, as well as the risk assessment paradigm.
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may be in agreement with Giordano et al., (2008) who point out that as knowledge grows,
empirical evidence must direct what is studied, how it is studied, and how the results are
interpreted in the future.
Overall the survey results provide an important snap-shot of toxicologists’ and
risk assessors’ knowledge about the science of risk assessment and hormesis, and their
opinions on the policies used by regulatory agencies to interpret the science. The
hormesis dose-response appears to be gaining acceptance as a legitimate biological
phenomenon worthy of attention. The detailed chi-square and logistic regression
analyses revealed that no single demographic or personal characteristic among the over
50 studied was routinely or dramatically associated with the respondents acceptance or
rejection of hormesis as a biological concept in risk assessment. A majority of the
scientists who took this survey appear to be guided by science and not predisposing
beliefs.
The fact that 1,247 subjects took on average 30 minutes of their time to complete
the entire 44 question technical survey and in many cases provide detailed and thoughtful
comments supports the idea that interest in hormesis is growing, as is a re-examination of
the underlying assumptions of risk assessment model in general. The field of risk
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assessment may truly be at a point where scientists are willing and eager to explore
models that reflect the true biology of dose-response.

5.3 Limitations
An opinion survey of this type is not without its limitations. High survey
response rates help ensure survey results are representative of the target population. The
anticipated response rate for this email-based internet survey was 25% based on the
literature for email delivered surveys (Hamilton, 2003; Kaplowitz et al., 2004). The
return rate, meaning those who clicked on the email invitation and opened the survey,
was 23% for the Society of Toxicology (SOT), close to what was expected. However the
SOT adjusted response rate after removing those who completed the demographics
section and did not continue was 18% representing 1,045 individuals, lower than hoped.
The Society for Risk Analysis (SRA) return and response rates were much lower at 16%
and 12% respectively. This was expected because of a limitation in the sampling frame
which consisted of a large fraction of risk management professionals such as aviation and
infrastructure professionals who have no knowledge of chemical or radiation risks. For
some survey research studies, a low response rate such as the one experienced by this
study may be considered problematic and give rise for concern about non-response bias.
However, for this particular survey, the concerns for non-response bias may not be
warranted because those respondents were representative of the societies from which they
were derived. SOT respondents were used to evaluate external validity because the SRA
did not supply comparative data and because of the sampling frame issues mentioned
earlier. The demographic characteristics of the SOT respondents are nearly identical to
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the demographic characteristics of the society as a whole. The comparative data are
considered highly reliable because they were supplied by SOT and were derived from
membership applications. In addition, the characteristics and responses of the present
hormesis survey respondents are nearly identical to SOT members who responded to a
survey on Risk Communication administered by George Mason University researchers
three months after the hormesis survey closed. The George Mason survey had an
adjusted response rate of 26% (n=937 SOT full members). The respondents to the two
surveys who were full members of SOT were closely matched with respect to gender,
years of experience and average age. Comparisons by country and region of residence in
the United States are identical. The only differences between the two surveys were in the
area of employment. The hormesis survey had 9% fewer academics, but 11% more
respondents employed by the government.
The internal measures also suggest bias may be low. No substantial differences
exist between those who started the survey and those who finished. The only notable
difference was that members of SRA dropped out of the survey at a slightly higher rate
than SOT members. This may be expected due to the sampling frame issues previously
described. Over twenty SRA members took the time to send an email to the link
provided on the invitation, to indicate that they were not familiar with chemical risk
assessment or the concept of hormesis and therefore declined to take the survey. No SOT
members sent emails indicating they were not familiar with the topic.
The final limitation is one found in all surveys, the concern that respondents
understand the meaning and intention of the question. A few of the open ended
comments indicated that in some instances respondents did not understand what was
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being asked by a particular question or meant by a specific term. However, these
comments were made mostly on the definition questions, for which some of the
respondents did not know whether the survey was asking for the regulatory definition or
their opinion. The definition questions did not impact the analysis of overall opinion.
Finally, many respondents indicated the survey would have been better if it had provided
the respondent with a Likert scale instead of the dichotomous responses. Admittedly, the
respondent was not informed in the Introduction or in the body of the surrey that the
instrument was designed to elicit responses that were not neutral or that would require
reclassification to accommodate statistical analysis.
None of these limitations are likely to adversely affect in a serious manner the
conclusions of this study. It is likely that these results are in fact generalizable to the
broader population of toxicologists and risk assessment professionals. The phenomenon
of hormesis appears to be recognized as a biological fact that should be seriously
considered when designing, conducting and interpreting future risk assessments.

90

CHAPTER 6
CONCLUSIONS
The goals of this study were to: 1) ascertain attitudes about hormesis and other
dose-response models; 2) identify whether the level of acceptance or rejection of
hormesis is based on knowledge of hormesis, existing social and political values, or
demographic characteristics; 3) evaluate potential for response bias; and 4) establish
research priorities for hormesis.
An examination of the study participants’ answers to the survey questions
indicates that a majority of toxicologists and risk assessors are knowledgeable about the
hormesis dose-response and in fact accept it as a phenomenon worthy of scientific
exploration and consideration. Further, respondents demonstrated through their
responses a strong desire to advance the science of risk assessment by taking into
consideration dose-response models and research results that more accurately reflect the
complexity of various biologic systems rather than employing an a priori default model
that results in predictable, linear, non-threshold outcomes.
Level of acceptance or rejection of hormesis among the scientists who
participated in this first- ever survey on the topic of hormesis was not explained by any of
the characteristics or predisposing values examined in this study, with the exception of
employment in government regulatory agencies or pharmaceutical companies. It was
speculated a priori that many non-scientific aspects of a participant’s background
including gender, education, work experience, membership in professional societies,
socio-economic and political views, employment history, and toxicological specialty,
may materially affect his/her opinion of hormesis and its utility in risk assessment.
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Therefore, data were collected on over 50 variables defining the above characteristics and
none was predictive of a profile of who would generally be open to either accept or reject
hormesis as a dose-response phenomenon. It was found unexpectedly that only
employment by a government regulatory agency was consistently predictive of a
respondent being less accepting of hormesis. Prior to the survey, this researcher
speculated that socio-economic and political views and gender would be consistently
associated with respondent attitudes about hormesis and risk assessment. Specifically, it
was thought that respondents with more liberal views and women would be less
accepting of hormesis as a dose-response model for risk assessment because the concept
is not entirely consistent with the now widely accepted precautionary principle, which
asserts that conservative protective measures must be taken when cause-and-effect
relationships have not been established, but only suggested by inconclusive studies.
However, the data show that most respondents appear to be willing to follow the
scientific evidence of discovery and investigation with regard to dose-response research
and not be influenced by existing political or social views or belief systems.
The survey clearly showed that those ever employed by government regulatory
agencies and those employed by pharmaceutical companies do not accept hormesis as a
widely generalizable phenomenon or a useful dose-response model. Furthermore,
respondents employed by government regulatory agencies had consistently more negative
opinions toward hormesis as a dose-response model. It has been speculated that for
government workers this difference may be due to bias based on agency policy or agency
culture. It could also be due to self-selection by those more likely to agree with the
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default dose-response model and the precautionary principle, who select for employment
in the regulatory environment.
The influence of non-response bias was evaluated through several internal and
external measures while keeping to the study promise of maintaining respondent
anonymity. Despite the lower than hoped for response rate, but because of the relatively
robust external validity measures for Society of Toxicology members, it is concluded that
respondents’ opinions are likely a reasonable representation of the societies of which they
are members.
Certainly a better understanding of hormesis and the desire to conduct studies that
elucidate the full range of biological responses will likely lead to adoption of different
strategies for evaluating dose-response as it applies to risk assessment, toxicology and
pharmacology. The survey results indicate that scientists are prepared to direct research
away from the a priori default models for evaluating adverse health effects at high doses
and begin to characterize and reflect the complex biological effects, both adverse and
beneficial, that may occur at low-levels of exposure. If this new approach or paradigm of
dose-response research takes root and grows, a follow-up survey of the present study
population may be in order.
Any future survey design should separately evaluate the knowledge and science
of dose-response from the regulatory approach to dose-response investigations in order to
avoid conflating science with public policy, which is often not scientifically based.
In conclusion, in order to truly understand how attitudes toward dose-response
evolve over time, a prospective cohort study could be initiated in cooperation with the
Society of Toxicology that administers a survey instrument similar to the one used in this
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study to student members of the Society with periodic follow-up to evaluate change in
attitudes and opinion according to the various characteristics examined in the present
investigation. Such a study would be valuable for understanding the level of acceptance
of the hormesis dose-response paradigm and for documenting changes in attitudes about
and the conduct of risk assessment, and what factors affect these changes in attitudes.
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APPENDIX A
SOCIETY OF TOXICOLOGY DEMOGRAPHIC INFORMATION
REQUEST LETTER
Amy C. Jones
Environmental Health Sciences, Morrill I, N344
University of Massachusetts
Amherst, Massachusetts 01003
April 7, 2009
Dr. Kenneth S. Ramos
President, Society of Toxicology
1821 Michael Faraday Drive, Suite 300
Reston, Virginia 20190
Dear Dr. Ramos:
I am a Full Member of the Society of Toxicology and member of the Society’s Carcinogenesis;
Ethical, Legal and Social Issues; Occupational and Public Health; and Risk Assessment Specialty
Sections. I am also a doctoral student at the University of Massachusetts doing work on
biological responses at low dose. In particular, I am interested in the hormesis dose-response
phenomenon. Last September, I surveyed Society of Toxicology and Society for Risk Analysis
members about their knowledge and opinions on the hormesis dose response model. The
responses to the survey comprise the basis of my PhD thesis.
The goals of the survey were to 1) ascertain respondents’ attitudes about various dose response
models, including hormesis; 2) determine the characteristics of people who would, if allowed by
the regulatory framework, take the potential for hormesis into account when designing and/or
interpreting risk assessments; and 3) identify whether the level of acceptance or rejection of
hormesis is based on scientific/educational training of the subject; predisposing social and
political values; or demographic characteristics.
I would like to evaluate the potential for response bias in my survey by comparing the
demographic characteristics of respondents who completed the survey with the overall
demographic characteristics of SOT membership. Without the overall SOT membership
distribution data, it will be impossible for me to assess response bias in a valid manner; and any
inference I draw on my survey’s results thus would be severely limited.
SOT requests its members to voluntarily provide the following information that would be very
helpful to my research:
• Gender
• Highest Degree
• Years of Experience
• Employment: Academia, Contract Research Organization, Government, Industry,
Military, Not Employed, Other, Research Institute, and Student

95

•

Areas of Interest: General Toxicology, Reproductive and Developmental, Drug
Discovery, Biotechnology, Carcinogenesis, Food Safety, Biological Modeling, etc.

I am requesting the Society provide me a summary of the above referenced demographic data. I
do not require personally identifiable information, just the overall frequency distribution data for
each demographic category. I will then compare the distribution of the above characteristics with
the characteristics of my respondents in order to assess response bias.
I thank you in advance for your kind attention to this request.
If you would like to speak to me directly, please do not hesitate to call me at 301-758-0547. My
email address is amyn@schoolph.umass.edu.
Sincerely,
Amy Jones
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APPENDIX B
SURVEY E-MAIL INVITATION
Dear Colleague,
I am a graduate student at the University of Massachusetts at Amherst, completing a
Ph.D. thesis on the hormesis dose-response. I invite you to participate in my research by
completing this survey to assess knowledge and opinions about dose response in general,
and hormesis in particular.
This survey is completely anonymous. Your responses will not be identified with you
personally. Responses will be assessed in aggregate only.
The link to the survey is:
http://www.surveymonkey.com/s.aspx?sm=n8uQQTBqX2wZ_2fweuyMfGAw_3d_3d
The Institutional Review Board (IRB) at the University of Massachusetts Amherst has
approved this study. If you have concerns about this study you may contact me directly
by email at amyn@schoolph.umass.edu or by phone at 301-758-0547. Alternatively, you
may contact the University’s Human Research Protection Office via email at
humansubjects@ora.umass.edu or by phone at 413-545-3428.
Final Survey results will be posted on the UMASS Environmental Health Sciences
website at the completion of the study.
You may withdraw from the survey at any time and may choose not to answer all
questions.
I appreciate your taking the time to complete this survey.
Sincerely,
Amy C. Jones
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APPENDIX C
DOCUMENTATION OF SURVEY INSTRUMENT FINAL TEXT

No.

Question

1

Section 2
If you have taken this survey
previously, please skip to the end.

2
3
4
5
6
7
8
9
10
11
12
13

Residence
Age
Sex
Degrees
Employers
Specialties
Yrs Exp
Memberships
Info Sources
Social
Economic
Political

14

15

16

Purpose
The purpose of this section is to obtain
information on age, sex, level of
education, employment history, and/or
geographical region
Potential respondents could have reveived
more than one link depending on society
membership.
Obtain important demographic information
Obtain important demographic information
Obtain important demographic information
Obtain important demographic information
Obtain important demographic information
Obtain important demographic information
Obtain important demographic information
Obtain important demographic information
Obtain important demographic information
Obtain important demographic information
Obtain important demographic information
Obtain important demographic information
The purpose of this section is to assess
your general knowledge about doseresponse assessment and various dose
response models.

Section 3
Dose-response assessment is a
necessary foundation for
understanding risk assessment.
Regulatory upper-bound
characterizations used in cancer risk
assessments provide accurate
estimates of the probability of
developing cancer at low doses.
Exposure to a genotoxic carcinogen,
no matter how small, theoretically
results in an increased cancer risk.
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Dose-response is the foundation for
toxicology. Do the respondents think is is
also the foundation for risk assessment?
Risk assessments performed pursuant to
certain regulatory frameworks require
specific models to be applied to the data.
Do the respondents agree with an example
of a default model?
Regulatory framework question. Do the
respondents agree with the current
regulatory framework for assessing
genotoxic compounds?
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17

18

19

20

21

22

23

24

25

Exposure to non-genotoxic
carcinogen, no matter how small,
theoretically results in an increased
cancer risk.
Exposure to ionizing radiation (e.g.
X-Rays), no matter how small,
theoretically results in increased
cancer risk.
The linear model employed in
cancer risk assessment overstates
risk in the low dose zone.

Regulatory framework question. Do the
respondents agree with the current
regulatory framework for assessing nongenotoxic compounds?
Regulatory framework question. Do the
respondents agree with the current
regulatory framework for assessing ionizing
radiation?
Regulatory framework question. How do the
respondents interpret output from the LNT
model?

The threshold dose-response
assumes no treatment related
responses occur below the
estimated threshold.
The linear non-threshold (LNT)
dose-response assumes a biological
response is directly proportional to
dose in the low dose zone.
The hormesis dose-response
exhibits biological responses at low
doses that are opposite to those
observed at higher doses, leading to
either a J-shaped or inverted U
shaped dose-response curve.
For effects other than
carcinogenisis, most toxicants act in
a manner consistent with the
following model:
Carcinogens typically act via the
following dose-response model:

Knowledge question. Do respondents agree
to the text book definition of a threshold
dose-response?

Have you ever conducted
experimental research in doseresponse?
In my research…
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Knowledge question. Do respondents agree
to the textbook definition of linear nonthreshold (LNT) dose-response.
Knowledge question. Do the respondents
agree to the definition of the hormesis doseresponse commonly published in the
literature?

Regulatory framework question. Which of
the two regulatory dose-response models
plus hormesis do the respondents prefer for
evaluating most toxicants?
Regulatory framework question. Which of
the two regulatory dose-response models
plus hormesis do the respondents prefer for
evaluating most toxicants?
How many people who answered the
survey have actually conducted dose
response research?
Of the people who evaluate dose-response
studies, how many have observed the
various dose-responses listed?
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Section 4
Have you ever attended a seminar,
workshop, or classroom
presentation on the topic of
hormesis?

The purpose of this section is to assess
your level of familiarity with hormesis.
Personal instruction and scholarly discourse
on hormesis is increasingly available. How
many respondents have experience with
these sources of information?

How commonly do you think
hormesis is observed in,

A research goal is to identify research gaps.
This question is intended to find out how
commonly respondents think hormesis
occurs in various types of studies.
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If you answered uncommon, rare,
artifactual, or do not know, to the
preceding question, is it because
you believe one of the following?

30

Any reproducible biological
response to a toxic chemical or
radiation exposure qualifies as an
"adverse effect".

This follow-on question asking why the
respondent answered in a particular way is
important. Responses to this question will
help identify whether the survey has strong
response bias. If high number of does not
apply, response bias favorable to hormesis
may be present.
A key component of the hormetic dose
response is that biological effects at low
doses could be either beneficial or
detrimental depending on the shape of the
curve and biologic endpoint. How many
respondents believe all measurable effects
are adverse?
How do respondents interpret the J-shaped
hormesis dose-response?

28

31

32

33

If a study reliably shows a J-Shaped
dose response curve, it implies low
dose effects could be beneficial
Sufficient data exist to suggest
hormesis occurs in a wide range of
species and endpoints following
low-dose exposure to a broad range
of chemical agents and physical
stressors.
If study reproducibly demonstrates
the hormesis dose-response, the
implication for low doses would be:
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How many respondents agree with data on
the occurrence of hormesis recently
published review articles by Calabrese and
others?

Do respondents understand the nature of
the J and inverted U shaped curves?
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34

35

36

37

38

39

40

41

Section 5
What is your perspective on current
state of chemical regulation?
What is your perspective on current
state of ionizing radiation
regulations?

Risk assessment procedures should
be modified to obtain potential
benefits associated with hormesis.
If a chemical exhibits a hormesis
dose-response, the risk assessment
should accommodate data.

If hormesis were accepted as the
default model for risk assessment,
current regulations should be reevaluated.
The phenomenon of hormesis
justifies a change in hazard assess
protocols (e.g. sample size, number
of doses, timing of doses).

Acceptance of hormesis decreases
the margin of safety in risk
assessments.
Hormetic model indicates that at low
doses risk of disease is significantly
reduced.
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The purpose of this section is to obtain
your opinion on risk assessment
principles and assess how you interpret
dose response models in conducting
risk assessments.
Regulatory policy question. What do
respondents think of the current state of
chemical regulation?
Regulatory policy question. What do
respondents think of the current state of
ionizing radiation regulations?
Regulatory policy question. Would
respondents be willing to modify risk
assessment procedures if the hormetic
dose response showed a protective
response at low doses?
Regulatory policy question. Would
respondents be willing to follow the doseresponse data instead of applying a default
model prescribed in a regulatory
framework?
Regulatory policy question. Would
respondents be willing to change the
regulatory decisions based on hormesis?
Regulatory policy question. Scholarly
articles have been published noting that
hormesis cannot be reliably detected using
the standard high dose study design. Do
respondents believe that hormesis is
common enough to change the hazard
identification model?
Regulatory policy question. Do
respondents belief that acceptance of
hormesis would decrease the margin of
safety in a risk assessment?
Regulatory policy question. How do the
respondents interpret the J-shaped doseresponse depicted in the figure provided?
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If hormesis is present, the traditional
use of safety factors not necessary.
42

43

44

45
46

If hormesis were accepted as the
default model for risk assessment,
current and past environmental risk
assessment decisions should be
formally re-evaluated?
Risk assessments based on the
hormesis dose-response could
address chemical mixtures as
effectively as linear and threshold
based risk assessments.

Section 6
Do you have any suggestions about
content we may have missed?
What could we have done to make
this survey better?
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Regulatory policy question. The regulatory
framework requires uncertainty factors to be
incorporated into derivation of the final "safe
dose". Would adoption of hormesis change
respondents attitudes toward safety
factors?
Regulatory policy question. Would
respondents be open to changing risk
assessment decisions if the regulatory
framework was changed to account for
hormesis?
Regulatory policy question. Chemicals
mixtures are not regulated. Do respondents
think risk assessments based on the
hormesis dose response could be effective
at assessing chemical mixtures?
Thank-you, please take another few
minutes to provide feedback on the
survey, then press the submit button.
Standard question for surveys.
Standard question for surveys.
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